This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Any dementia
KRA_PSY_DEMENTIA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
21782 |
4. Check minimum number of eventsNone |
21782 |
5. Include endpointsNone |
21782 |
6. Filter based on genotype QC (FinnGen only) |
21782 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF9
Any dementia
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 21782 | 9844 | 11938 |
| Unadjusted period prevalence (%) | 4.40 | 3.36 | 5.26 |
| Median age at first event (years) | 79.82 | 80.21 | 79.50 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 8523
- Matched controls
- 73193
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N06DX01
ATC
memantine; oral
55.4
323.0
3675
987
G30.0
ICD-10 Finland
Alzheimer disease with early onset
411.0
323.0
583
13
SPAT1053
SPAT
Memory test
4.3
323.0
3689
11021
N06DA04
ATC
galantamine; oral
22.4
323.0
834
352
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
8.6
323.0
2570
3490
G30.8
ICD-10 Finland
Other Alzheimer disease
51.4
323.0
969
182
N05AH04
ATC
quetiapine; oral
5.3
323.0
2113
4268
P20
ICPC
Memory disturbance
8.2
323.0
3965
7024
A28
ICPC
Limited function/disability NOS
4.0
323.0
3022
8908
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
31.2
323.0
806
244
F03
ICD-10 Finland
Unspecified dementia
59.8
323.0
2096
397
G30
ICD-10 Finland
Alzheimer disease
47.3
323.0
504
97
P70
ICPC
Dementia
23.3
323.0
799
323
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
73.3
323.0
414
51
G30.1
ICD-10 Finland
Alzheimer disease with late onset
67.9
323.0
3210
644
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
141.4
323.0
1541
114
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
4.2
323.0
1596
3833
SPAT1245
SPAT
Provision of support and information to patient’s family members
5.6
323.0
1069
1812
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
47.5
323.0
1385
297
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
71.6
323.0
690
90
N05AX08
ATC
risperidone; systemic
12.6
323.0
1959
1690
SPAT1216
SPAT
Assessment of functional ability
3.0
323.0
2609
9275
N06DA02
ATC
donepezil; oral
46.3
323.0
3286
978
F01.9
ICD-10 Finland
Vascular dementia, unspecified
50.9
323.0
455
81
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
98.4
323.0
1640
177
N06DA03
ATC
rivastigmine; oral, transdermal
41.9
323.0
2053
550
R53
ICD-10 Finland
Malaise and fatigue
2.9
316.2
2535
9425
TAB00
NOMESCO Finland
Lumbar puncture
7.5
310.4
801
996
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
231.2
309.8
336
13
AA1AD
NOMESCO Finland
CT of head and brain
2.5
307.3
3311
14614
F06.7
ICD-10 Finland
Mild cognitive disorder
7.4
304.9
794
1000
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
4.6
296.5
1170
2456
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
217.3
291.2
317
13
R41.3
ICD-10 Finland
Other amnesia
7.2
286.9
765
995
SPAT1234
SPAT
Support of social functional capacity
4.9
280.6
1031
2002
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
275.6
2397
9231
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.4
272.7
3365
15689
R41.0
ICD-10 Finland
Disorientation, unspecified
7.4
269.3
699
871
N03AG01
ATC
valproic acid; systemic, rectal
5.3
242.6
823
1452
F05.1
ICD-10 Finland
Delirium superimposed on dementia
741.9
242.5
252
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.6
236.2
2214
8770
L28
ICPC
Limited function/disability (L)
2.5
212.3
2173
8947
XA800
NOMESCO Finland
Neuropsychological investigation
6.3
209.2
607
878
SPAT1254
SPAT
Administration of medicine
2.5
204.5
1906
7436
N05BA04
ATC
oxazepam; oral
2.3
204.2
2462
10973
N06AX11
ATC
mirtazapine; oral
2.2
200.8
3006
14782
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
4.7
197.9
741
1446
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
66.3
196.7
240
32
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
182.7
1691
6519
N05AH03
ATC
olanzapine; systemic
5.2
182.0
624
1103
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
30.3
181.5
257
75
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
176.1
2700
13236
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
+∞
168.5
171
*
G20
ICD-10 Finland
Parkinson disease
4.4
161.9
647
1340
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.3
158.6
530
907
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.8
147.7
1084
3608
A06AD11
ATC
lactulose; oral
2.3
147.4
1726
7402
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.0
147.1
956
2939
N06AB10
ATC
escitalopram; oral
2.4
146.6
1438
5645
WYA20
NOMESCO Finland
Home visit
9.6
146.5
321
298
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
4.4
144.9
577
1188
F05.9
ICD-10 Finland
Delirium, unspecified
6.6
143.1
398
539
A04
ICPC
Weakness/tiredness general
2.4
142.7
1470
5912
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.2
139.5
817
2331
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.7
138.0
665
1627
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
+∞
134.9
137
*
F00.00
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
209.5
131.9
144
6
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.2
130.5
772
2213
N05AD01
ATC
haloperidol; systemic
5.3
128.7
429
729
SPAT1229
SPAT
Assessment of need for aid
2.5
127.9
1140
4226
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
127.5
1493
6353
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
390.8
127.4
135
*
N05BA06
ATC
lorazepam; systemic, sublingual
3.3
117.4
653
1785
U04
ICPC
Incontinence urine
3.2
116.9
691
1973
SPAT1172
SPAT
Guidance concerning hydration
4.6
114.0
426
819
N06AB04
ATC
citalopram; systemic
2.0
110.2
1810
8814
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.0
109.2
693
2078
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.7
106.7
844
2906
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
6.1
106.2
310
447
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.5
105.7
546
1407
N06AX26
ATC
vortioxetine; oral
3.9
104.7
466
1059
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
7.3
104.4
269
326
S72.0
ICD-10 Finland
Fracture of neck of femur
3.6
103.3
520
1312
N87
ICPC
Parkinsonism
5.8
103.1
316
485
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
103.0
1455
6651
I95.1
ICD-10 Finland
Orthostatic hypotension
3.4
102.6
554
1477
G31.0
ICD-10 Finland
Circumscribed brain atrophy
18.9
101.3
164
76
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
7.7
99.4
247
283
S01.0
ICD-10 Finland
Open wound of scalp
2.6
98.9
835
2979
SPAT1301
SPAT
No procedures
1.7
97.8
3238
19658
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
96.9
1432
19677
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
858.9
95.4
99
*
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.0
93.4
1394
6490
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
31.9
91.9
128
35
F0019, G301
ICD-10 Finland
NA
+∞
91.5
93
*
W19
ICD-10 Finland
Unspecified fall
2.3
91.3
948
3759
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
89.3
1231
5539
109
Kela drug reimbursment
Multiple sclerosis
14.8
88.2
156
92
R55
ICD-10 Finland
Syncope and collapse
2.0
88.2
1241
5631
G35
ICD-10 Finland
Multiple sclerosis
9.0
87.9
198
193
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
4.6
87.6
327
627
F01.2
ICD-10 Finland
Subcortical vascular dementia
27.4
85.2
123
39
SPAT1101
SPAT
Orthostatic test
2.7
84.7
661
2244
S06.0
ICD-10 Finland
Concussion
2.3
84.1
919
3725
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
92.6
82.4
96
9
SPAT1360
SPAT
Extensive global examination
2.2
81.5
900
3664
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
80.5
1798
9597
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.0
80.2
1226
5729
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
14.5
78.7
140
84
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
18.7
78.5
127
59
SPAT1304
SPAT
Counselling and guidance related to ageing
2.1
77.9
1053
4678
F00
ICD-10 Finland
Dementia in Alzheimer disease
29.6
77.1
109
32
N02AA05
ATC
oxycodone; systemic
1.8
75.3
1562
8113
F009, G309
ICD-10 Finland
NA
344.8
75.2
80
*
A29
ICPC
General symptom/complaint other
2.0
74.6
1149
5371
N04BD01
ATC
selegiline; oral
5.0
74.3
258
458
SPAT1252
SPAT
Overall medication plan or its review
2.2
74.0
857
3558
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.7
73.8
270
507
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.4
73.7
395
1043
F21
ICPC
NA
8.0
72.1
174
191
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.8
71.3
330
774
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.9
69.6
246
445
SPAT1167
SPAT
Insertion of urinary catheter
2.8
68.5
484
1543
F01
ICD-10 Finland
Vascular dementia
21.0
66.9
104
43
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.5
66.8
255
500
R42
ICD-10 Finland
Dizziness and giddiness
1.6
65.5
2134
12571
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.2
64.3
740
3056
SPAT1246
SPAT
Screening of depression or other psychiatric problem
3.7
63.8
296
696
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
292.1
63.6
68
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
4.9
63.4
221
394
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.3
62.6
249
509
N02BE01
ATC
paracetamol; systemic, rectal
1.7
62.4
7328
57433
Z75.5
ICD-10 Finland
Holiday relief care
11.1
61.6
123
96
Z02.7
ICD-10 Finland
Issue of medical certificate
2.4
61.3
586
2210
N30.0
ICD-10 Finland
Acute cystitis
1.8
61.0
1221
6225
N03AX14
ATC
levetiracetam; systemic
3.6
61.0
301
745
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.5
60.9
522
1862
F01.0
ICD-10 Finland
Vascular dementia of acute onset
187.4
59.3
65
*
F00.14
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type
68.3
58.9
71
9
R33
ICD-10 Finland
Retention of urine
1.9
58.5
932
4386
AXX01
SPAT
NA
4.2
58.0
236
493
L03AB07
ATC
interferon beta-1a; parenteral
25.4
57.9
85
29
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
17.0
57.6
96
49
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.0
56.9
785
3493
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.1
56.9
733
3172
N03AE01
ATC
clonazepam; systemic
2.3
56.7
550
2089
N06AX16
ATC
venlafaxine; oral
2.0
56.5
809
3653
N04BD02
ATC
rasagiline; oral
6.2
56.4
161
226
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.7
56.1
409
1330
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.9
56.1
246
551
N06AB06
ATC
sertraline; oral
2.1
56.0
686
2903
E86
ICD-10 Finland
Volume depletion
3.4
55.7
290
749
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.1
54.6
645
2686
C03CA01
ATC
furosemide; systemic
1.5
53.9
3032
20036
N29
ICPC
Neurological sympt/complt other
3.6
52.6
251
604
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
6.6
51.8
141
186
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.1
51.2
674
2935
SPAT1139
SPAT
Nutrition survey
2.8
50.2
346
1085
F0009, G300
ICD-10 Finland
NA
+∞
50.1
51
*
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.8
50.0
940
4673
N03AF02
ATC
oxcarbazepine; oral
3.1
49.7
296
844
G04BD12
ATC
mirabegron; oral
1.7
49.1
1169
6254
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.8
49.0
1029
5299
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.9
48.5
821
3934
193
Kela drug reimbursment
Rasagiline
6.6
47.9
130
171
N86
ICPC
Multiple sclerosis
10.1
47.9
100
86
L03AX13
ATC
glatiramer acetate; parenteral
25.9
47.5
69
23
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
47.4
785
3734
S70.0
ICD-10 Finland
Contusion of hip
2.6
46.3
362
1224
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
35.7
46.1
62
15
N28
ICPC
Limited function/disability (N)
3.7
45.9
211
493
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
45.8
893
4486
130
Kela drug reimbursment
Malignant tumour
0.4
45.8
253
4817
F22.0
ICD-10 Finland
Delusional disorder
4.4
45.6
175
346
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.8
44.9
914
4654
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.3
44.8
451
1744
P29
ICPC
Psychological sympt/compl other
2.9
44.5
299
921
N05AA02
ATC
levomepromazine; systemic
2.7
44.3
333
1100
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.1
43.6
260
741
F05.8
ICD-10 Finland
Other delirium
6.3
43.6
122
168
N04BC04
ATC
ropinirole; oral
4.2
43.5
173
355
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.5
42.8
216
545
F10.73
ICD-10 Finland
Residual or late-onset psychosis caused by alcohol dementia
18.1
42.6
69
33
N06AX21
ATC
duloxetine; oral
1.9
42.2
718
3441
SPAT1262
SPAT
Handing over of treatment supplies
1.5
41.6
1764
10861
F00.1
ICD-10 Finland
Dementia in Alzheimer disease with late onset
378.0
41.6
44
*
A10AE04
ATC
insulin glargine; parenteral
1.8
41.3
847
4315
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
39.8
2819
19153
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.6
39.8
1361
7973
N05AB03
ATC
perphenazine; systemic, rectal
2.8
39.5
276
875
F0014, G301
ICD-10 Finland
NA
+∞
39.3
40
*
Z01.9
ICD-10 Finland
Special examination, unspecified
2.0
39.2
523
2284
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.5
39.2
318
1098
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.9
39.1
633
2979
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
4.0
39.0
166
363
R11
ICD-10 Finland
Nausea and vomiting
1.9
38.5
640
3039
N04AA02
ATC
biperiden; systemic
3.7
38.4
178
420
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
38.1
430
1751
H02AB02
ATC
dexamethasone; systemic
0.5
38.1
295
5027
F01.24
ICD-10 Finland
Subcortical vascular dementia other additional symptoms of mixed type
94.9
38.1
44
*
N03AX09
ATC
lamotrigine; oral
2.9
38.0
245
738
N05BA01
ATC
diazepam; systemic, rectal
1.6
37.7
1051
5839
K90
ICPC
Stroke/cerebrovascular accident
2.4
37.7
345
1270
G72.8
ICD-10 Finland
Other specified myopathies
3.6
37.2
176
422
N04BX02
ATC
entacapone; oral
9.1
36.5
80
76
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
36.1
1102
6265
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.9
35.9
156
348
N03AF01
ATC
carbamazepine; oral, rectal
2.1
35.8
442
1872
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.2
35.6
400
1626
N05AH02
ATC
clozapine; systemic
5.5
35.3
109
171
J01EA01
ATC
trimethoprim; systemic
1.4
34.9
1909
12308
N30.9
ICD-10 Finland
Cystitis, unspecified
2.0
34.9
463
2019
F02.09
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
317.1
34.8
37
*
N99
ICPC
Neurological disease other
3.9
34.6
148
326
F001, G301
ICD-10 Finland
NA
60.5
34.5
42
6
C10AA01
ATC
simvastatin; oral
1.3
34.4
4570
34053
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
33.0
33.8
46
12
F01.3
ICD-10 Finland
Mixed cortical and subcortical vascular dementia
27.6
33.8
48
15
SPAT1263
SPAT
Sampling
1.3
33.7
3510
25189
G40
ICD-10 Finland
Epilepsy
5.2
33.6
110
185
F01.34
ICD-10 Finland
Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type
159.5
33.6
37
*
164
Kela drug reimbursment
Fingolimod
58.8
33.5
41
6
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
5.0
33.3
113
198
R1250
NOMESCO Finland
Evaluation of functional capability
3.1
33.3
197
561
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
33.0
1360
8275
S00.0
ICD-10 Finland
Superficial injury of scalp
3.0
32.7
201
588
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.9
32.4
211
640
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
12.6
32.4
60
41
N05AX12
ATC
aripiprazole; systemic
3.7
32.2
150
356
G04BD08
ATC
solifenacin; oral
1.7
32.2
689
3545
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.7
31.9
798
4299
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
3.8
31.9
142
325
F00, F03
ICD-10 Finland
NA
+∞
31.4
32
*
SPAT1279
SPAT
Preparation of immediate hospitalisation
3.9
31.4
137
308
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.2
31.1
325
1279
N17
ICPC
Vertigo/dizziness
1.5
31.0
1038
6021
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
30.9
1297
7905
F01.80
ICD-10 Finland
Other specified vascular dementia without additional symptoms
48.0
30.9
39
7
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
3.5
30.7
149
366
353
Kela drug reimbursment
Cladribine and fingolimod
63.9
30.6
37
5
N05CD07
ATC
temazepam; oral
1.5
30.6
1071
6273
J01CA08
ATC
pivmecillinam; oral
1.3
30.5
2544
17559
183
Kela drug reimbursment
Lamotrigin and topiramate
6.1
30.3
86
122
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.0
30.3
434
1950
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
18.8
30.3
48
22
R32
ICD-10 Finland
Unspecified urinary incontinence
2.3
30.0
286
1077
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.5
29.6
143
351
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
29.5
2615
18200
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
4.9
29.2
99
174
F01.1
ICD-10 Finland
Multi-infarct dementia
137.8
28.8
32
*
SPAT1251
SPAT
Organisation of medication
2.1
28.6
331
1361
F02.89*E03.9
ICD-10 Finland
Dementia in hypothyroidism, acquired
+∞
28.5
29
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.7
28.4
588
2993
N18
ICPC
Paralysis/weakness
2.6
28.4
215
716
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
28.4
2059
13869
N05AN01
ATC
lithium; oral
3.2
28.3
158
433
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
28.2
561
2819
H02AA02
ATC
fludrocortisone; oral
4.5
28.2
105
204
M03BX01
ATC
baclofen; systemic
3.2
28.0
152
408
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.9
27.9
181
549
F00.24
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type
71.1
27.8
33
*
P99
ICPC
Psychological disorders other
3.4
27.6
140
357
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
3.2
27.6
149
399
K91
ICPC
Cerebrovascular disease
2.9
27.5
173
513
F0029, G308
ICD-10 Finland
NA
+∞
27.5
28
*
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
3.2
27.4
155
427
S06.3
ICD-10 Finland
Focal brain injury
3.3
27.4
145
382
G41.9
ICD-10 Finland
Status epilepticus, unspecified
5.5
27.4
84
132
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.9
27.3
92
161
F00.11
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism
43.1
27.3
35
7
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
6.8
27.2
71
90
R25.1
ICD-10 Finland
Tremor, unspecified
2.2
27.2
288
1141
Z29
ICPC
Social problem NOS
3.1
26.9
159
452
B03BA03
ATC
hydroxocobalamin; parenteral
1.7
26.9
545
2756
L82
ICD-10 Finland
Seborrhoeic keratosis
0.7
26.8
716
8973
SPAT1125
SPAT
Stoma care and guidance
2.7
26.7
194
630
R44.3
ICD-10 Finland
Hallucinations, unspecified
6.9
26.6
69
87
R63.4
ICD-10 Finland
Abnormal weight loss
2.0
26.5
336
1438
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.1
26.5
325
1373
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
26.4
579
2998
R44.1
ICD-10 Finland
Visual hallucinations
5.8
26.3
77
114
L03AB08
ATC
interferon beta-1b; parenteral
18.1
26.2
42
20
K59.0
ICD-10 Finland
Constipation
1.8
26.2
485
2381
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
3.9
26.0
110
242
N02AJ06
ATC
codeine and paracetamol; systemic
0.7
26.0
1808
19375
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
25.7
2138
14666
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.5
25.7
127
318
N03AX18
ATC
lacosamide; systemic
5.6
25.7
77
118
P28
ICPC
Limited function/disability (P)
5.9
25.6
74
108
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
2.4
25.6
223
802
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.7
25.6
689
8625
F0011, G301
ICD-10 Finland
NA
+∞
25.5
26
*
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
11.1
25.5
50
39
N05CF01
ATC
zopiclone; oral
1.3
25.5
2600
18375
SPAT1307
SPAT
Psychosocial counselling and guidance
2.3
25.2
240
904
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.5
25.0
200
687
N19
ICPC
Speech disorder
3.1
24.9
141
390
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
24.9
1336
8517
N04BB01
ATC
amantadine; oral
2.9
24.9
158
473
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.9
24.8
162
492
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.6
24.8
624
3356
H46
ICD-10 Finland
Optic neuritis
6.0
24.5
70
101
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
8.8
24.4
54
53
M01AH05
ATC
etoricoxib; oral
0.8
24.4
3040
30326
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
5.8
24.2
71
106
I50.9
ICD-10 Finland
Heart failure, unspecified
1.4
24.0
1295
8257
A04AA02
ATC
granisetron; systemic, transdermal
0.5
23.9
146
2696
T90.5
ICD-10 Finland
Sequelae of intracranial injury
4.0
23.9
100
218
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.7
23.8
169
544
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.4
23.6
86
1924
Z60.8
ICD-10 Finland
Other problems related to social environment
12.8
23.5
43
29
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
5.6
23.5
71
110
N88
ICPC
Epilepsy
5.7
23.4
70
107
W06
ICD-10 Finland
Fall involving bed
4.0
23.4
96
206
L04AA27
ATC
fingolimod; oral
49.9
23.3
29
5
R35
ICD-10 Finland
Polyuria
1.6
23.2
594
3210
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.5
23.2
986
6001
Z28
ICPC
Limited function/disability (Z)
5.7
23.2
69
105
SPAT1138
SPAT
Guidance concerning bowel function
2.8
23.1
152
465
N04BC05
ATC
pramipexole; oral
1.6
22.9
636
3510
K08.3
ICD-10 Finland
Retained dental root
1.7
22.9
542
2868
P15
ICPC
Chronic alcohol abuse
2.7
22.8
159
505
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.7
22.6
101
234
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.7
22.6
162
525
N03AB02
ATC
phenytoin; systemic
3.3
22.5
116
302
G04CA02
ATC
tamsulosin; oral
1.3
22.3
2364
16725
SPAT1284
SPAT
Extensive health certificate
2.4
22.3
201
737
A10BB01
ATC
glibenclamide; oral
1.8
22.2
379
1811
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
107.6
22.1
25
*
WX212
NOMESCO Finland
Femoral plexus blockade
2.5
22.1
186
660
A27
ICPC
Fear of other disease NOS
1.8
22.1
374
1784
A10AE05
ATC
insulin detemir; parenteral
1.8
21.9
420
2085
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
4.2
21.8
86
178
Y94.0
ICD-10 Finland
Accident at home
2.6
21.8
167
561
A01
ICPC
Pain general/multiple sites
1.6
21.7
606
3349
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.4
21.7
87
1872
F01.39
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without information on additional symptoms
40.2
21.6
28
6
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.6
21.6
661
3735
F0024, G308
ICD-10 Finland
NA
+∞
21.6
22
*
A69
ICPC
General and Unspecified, Other reason for encounter NEC
2.3
21.5
208
793
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.7
21.4
492
2582
Z13.3
ICD-10 Finland
Special screening examination for mental and behavioural disorders
14.5
21.4
37
22
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.6
21.4
670
3811
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.3
21.3
206
782
F02.89
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without information of additional symptoms
24.3
21.3
31
11
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.9
21.3
312
1413
Z51.88
ICD-10 Finland
Other specified medical care
2.4
21.3
189
688
SPAT1157
SPAT
Guidance concerning treatment of mouth and mucous membranes
3.0
21.3
124
353
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
21.2
1969
13663
XF606
NOMESCO Finland
Ortostatic test
3.6
21.2
98
234
D21
ICPC
Swallowing problem
2.7
21.1
146
463
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
5.1
21.1
69
118
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
2.7
21.1
146
464
G04BD04
ATC
oxybutynin; oral, transdermal
1.7
21.1
462
2393
Z51.5
ICD-10 Finland
Palliative care
1.6
21.0
594
3295
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
3.5
20.8
101
251
SPAT1050
SPAT
Extensive neurological examination
2.2
20.8
211
823
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
38.7
20.7
27
6
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
4.1
20.7
84
179
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
2.3
20.7
196
737
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.7
20.7
463
2412
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
20.6
1397
9240
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.0
20.6
290
1294
F06.0
ICD-10 Finland
Organic hallucinosis
10.1
20.6
42
36
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.8
20.5
1473
15813
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
4.2
20.4
79
161
SPAT1127
SPAT
Enema
3.4
20.4
102
260
D12
ICPC
Constipation
1.9
20.3
316
1465
SPAT1153
SPAT
Removal of sutures
0.8
20.3
2107
21619
F00.01
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism
99.0
20.2
23
*
S01.8
ICD-10 Finland
Open wound of other parts of head
3.1
20.2
114
316
L75
ICPC
Fracture: femur
2.8
20.1
132
406
L57.0
ICD-10 Finland
Actinic keratosis
0.7
20.1
551
6898
AA1AA
NOMESCO Finland
Head X-ray examination
3.4
20.1
100
254
G91.0
ICD-10 Finland
Communicating hydrocephalus
4.8
20.1
69
125
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
5.6
20.0
60
93
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.9
19.8
312
1454
SPAT1276
SPAT
Outlining of treatment with patient or their family members
2.2
19.8
213
851
R1250
SPAT
NA
4.6
19.7
70
131
F10.24
ICD-10 Finland
Alcohol depence active use
3.5
19.7
93
227
F0232, G20
ICD-10 Finland
NA
+∞
19.6
20
*
EBA30
NOMESCO Finland
Excision of root of tooth
1.7
19.6
421
2164
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.6
19.6
92
223
A10BB12
ATC
glimepiride; oral
1.5
19.6
693
4052
UKC02
NOMESCO Finland
Cystoscopy
1.3
19.5
1572
10667
N27
ICPC
Fear of neurological disease other
2.5
19.5
151
514
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
17.8
19.4
31
15
J01MA02
ATC
ciprofloxacin; systemic
1.2
19.4
3117
23128
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
5.8
19.4
56
83
N05AD03
ATC
melperone; systemic
3.7
19.3
88
208
L01BC06
ATC
capecitabine; oral
0.4
19.3
73
1608
F20.9
ICD-10 Finland
Schizophrenia, unspecified
2.9
19.2
121
363
G31.1
ICD-10 Finland
Senile degeneration of brain, not elsewhere classified
15.3
19.0
32
18
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
2.6
19.0
147
499
S42.2
ICD-10 Finland
Fracture of upper end of humerus
1.8
19.0
369
1844
WX402
NOMESCO Finland
General anaesthesia
0.7
18.9
580
7114
IAB14
NOMESCO Finland
Geriatric psychiatry consultation
7.6
18.9
45
51
P03
ICPC
Feeling depressed
1.8
18.9
352
1737
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
18.8
2782
20422
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
2.6
18.7
138
455
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
4.1
18.6
75
160
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
4.4
18.6
68
132
-2
ICPC
NA
4.8
18.6
63
113
P05
ICPC
Senility, feeling/behaving old
4.9
18.4
62
110
I95.9
ICD-10 Finland
Hypotension, unspecified
2.5
18.4
144
492
F00.09
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking
63.2
18.4
22
*
F01.23
ICD-10 Finland
Subcortical vascular dementia other additional symptoms, mainly depression
30.8
18.3
25
7
SPAT1260
SPAT
Consultation of another employee
1.3
18.3
1465
9917
Z03
ICPC
Housing/neighbourhood problem
4.5
18.2
66
127
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
4.4
18.2
68
135
N04BC09
ATC
rotigotine; transdermal
5.0
18.1
59
101
XKD06
NOMESCO Finland
Physiologic investigation of micturition
1.9
18.1
288
1345
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.2
18.1
180
696
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
1.7
18.1
369
1868
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
4.4
17.9
66
129
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.5
17.9
147
517
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
5.0
17.7
58
100
S22.3
ICD-10 Finland
Fracture of rib
1.6
17.6
489
2701
F01.8
ICD-10 Finland
Other vascular dementia
29.5
17.5
24
7
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.8
17.4
332
1649
2AB04
NOMESCO Finland
NA
14.4
17.4
30
18
S28
ICPC
Limited function/disability (S)
4.2
17.4
67
137
F00.2
ICD-10 Finland
Dementia in Alzheimer disease, atypical or mixed type
163.4
17.4
19
*
F01.84
ICD-10 Finland
Other specified vascular dementia other mixed symptoms of mixed type
86.1
17.4
20
*
G04BD07
ATC
tolterodine; oral
1.6
17.4
443
2393
R29.6
ICD-10 Finland
Tendency to fall, not elsewhere classified
5.2
17.3
55
92
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
5.7
17.2
50
75
S97
ICPC
Chronic ulcer skin
1.6
17.2
489
2716
A03FA01
ATC
metoclopramide; systemic, rectal
0.7
16.9
945
10535
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.9
16.9
264
1227
L76
ICPC
Fracture: other
2.0
16.9
230
1017
R5110
SPAT
NA
2.0
16.9
232
1029
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.8
16.9
305
1489
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
2.5
16.9
137
479
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
10.1
16.9
34
29
F99
ICD-10 Finland
Mental disorder, not otherwise specified
3.1
16.8
96
270
U13
ICPC
Bladder symptom/complaint other
1.9
16.8
258
1194
S20.2
ICD-10 Finland
Contusion of thorax
1.7
16.8
329
1648
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
3.0
16.7
97
277
R45.5
ICD-10 Finland
Hostility
45.2
16.7
21
*
F00.04
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type
+∞
16.7
17
*
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
3.9
16.6
70
156
G04BD09
ATC
trospium; oral
1.9
16.6
238
1073
N06AX12
ATC
bupropion; oral
2.1
16.5
183
744
F00.13
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression
154.8
16.4
18
*
TKC20
NOMESCO Finland
Catheterisation of bladder
1.5
16.4
629
3740
N05BA09
ATC
clobazam; oral
6.3
16.3
44
60
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
4.5
16.3
58
110
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.8
16.3
298
1460
NF1AA
NOMESCO Finland
Hip X-ray examination
1.4
16.3
769
4764
L04AA31
ATC
teriflunomide; oral
17.2
16.2
26
13
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
3.5
16.2
78
195
R40.2
ICD-10 Finland
Coma, unspecified
3.2
16.2
85
227
F60.9
ICD-10 Finland
Personality disorder, unspecified
4.8
15.9
54
98
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
7.2
15.8
39
47
F07.9
ICD-10 Finland
Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
16.0
15.8
26
14
H04AA01
ATC
glucagon; nasal, parenteral
2.9
15.8
97
288
LAITO
NOMESCO Finland
NA
43.0
15.8
20
*
SPAT1281
SPAT
Other administrative function
1.5
15.8
594
3518
WF049
NOMESCO Finland
Radiotherapy of metastasis
0.4
15.8
82
1601
103
Kela drug reimbursment
Diabetes, insulin-treated
1.2
15.7
2261
16465
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.8
15.7
2102
21116
F009, F03
ICD-10 Finland
NA
+∞
15.7
16
*
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
8.4
15.7
35
36
G04BD11
ATC
fesoterodine; oral
1.8
15.6
283
1382
F32
ICD-10 Finland
Depressive episode
1.9
15.6
238
1098
R50.9
ICD-10 Finland
Fever, unspecified
1.4
15.6
966
6276
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
15.5
2428
17848
F00.23
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression
77.4
15.5
18
*
F00.12
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations
30.1
15.4
21
6
N06AB03
ATC
fluoxetine; oral
1.4
15.4
757
4724
N05AC02
ATC
thioridazine; oral
2.4
15.4
130
463
SPAT1240
SPAT
Therapeutic discussion
1.6
15.4
459
2579
E000001
ATC
NA
1.3
15.3
1307
8911
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
15.3
470
2657
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.5
15.3
159
2492
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.9
15.2
238
1109
N05BE01
ATC
buspirone; oral
2.1
15.1
171
704
P76
ICPC
Depressive disorder
1.9
15.0
241
1132
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
2.7
15.0
108
352
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
2.9
15.0
92
273
R2110
NOMESCO Finland
Giving the first information
1.6
15.0
401
2194
N05AF03
ATC
chlorprothixene; systemic
2.3
15.0
145
555
R45.1
ICD-10 Finland
Restlessness and agitation
10.9
15.0
29
23
A46
ICD-10 Finland
Erysipelas
1.3
15.0
1122
7504
N06AX03
ATC
mianserin; oral
1.7
14.9
332
1728
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
5.6
14.9
44
68
H48.1*G35
ICD-10 Finland
Retrobulbar neuritis in multiple sclerosis
40.8
14.9
19
*
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.3
14.8
139
525
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.7
14.8
302
1531
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
2.3
14.8
135
502
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.0
14.8
201
891
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
3.7
14.7
66
156
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.0
14.7
179
759
F01.21
ICD-10 Finland
Subcortical vascular dementia without additional symptoms, mainly paranoidism
51.6
14.7
18
*
XA400
NOMESCO Finland
EEG
3.9
14.7
61
135
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.6
14.6
362
1941
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
4.3
14.6
55
111
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
6.8
14.6
37
47
F02.80
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without additional symptoms
28.7
14.5
20
6
F05.0
ICD-10 Finland
Delirium not superimposed on dementia, so described
5.0
14.5
47
81
F01.89
ICD-10 Finland
Other specified vascular dementia without information on additional symptoms
137.6
14.5
16
*
B01AA03
ATC
warfarin; systemic
1.2
14.5
1946
14040
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.5
14.5
118
414
IGY99
NOMESCO Finland
Other psychiatric treatment contact
3.8
14.3
61
138
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.0
14.3
180
774
F00.21
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism
32.7
14.3
19
5
Z75.0
ICD-10 Finland
Medical services not available in home
8.6
14.2
31
31
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.7
14.2
328
1727
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
0.6
14.1
243
3354
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
3.0
14.1
84
246
E87.6
ICD-10 Finland
Hypokalaemia
1.8
14.0
242
1168
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.9
14.0
205
935
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
0.8
14.0
843
9316
R60.0
ICD-10 Finland
Localized oedema
1.3
13.9
933
6134
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.3
13.8
1101
7427
S09.9
ICD-10 Finland
Unspecified injury of head
2.7
13.8
95
305
F0012, G301
ICD-10 Finland
NA
+∞
13.7
14
*
F02.31
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly paranoidism
+∞
13.7
14
*
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
1.9
13.7
197
891
S06.2
ICD-10 Finland
Diffuse brain injury
3.1
13.7
76
212
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
3.0
13.7
80
231
R13
ICD-10 Finland
Dysphagia
1.5
13.7
502
2958
F00.29
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms
68.9
13.6
16
*
F002, G308
ICD-10 Finland
NA
68.9
13.6
16
*
4AA23
NOMESCO Finland
NA
129.0
13.6
15
*
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.9
13.5
195
886
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
2.7
13.4
92
294
A04AA01
ATC
ondansetron; systemic, rectal
0.6
13.4
210
2957
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
3.1
13.3
74
207
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.1
13.3
160
676
S01
ICD-10 Finland
Open wound of head
2.6
13.3
98
326
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
13.3
847
5524
SPAT1014
SPAT
Treatment of eyes
2.1
13.3
148
607
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
4.0
13.2
53
114
B01AC07
ATC
dipyridamole; systemic
1.6
13.2
386
2158
S01.9
ICD-10 Finland
Open wound of head, part unspecified
2.3
13.2
119
441
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
2.9
13.1
80
237
RT250
NOMESCO Finland
NA
10.2
13.1
26
22
IGP01
NOMESCO Finland
Psychiatric family contact
8.3
13.1
29
30
Z73.6
ICD-10 Finland
Limitation of activities due to disability
2.7
13.1
90
289
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.8
13.0
1570
16003
B01AC04
ATC
clopidogrel; oral
1.3
13.0
1554
11038
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
2.8
13.0
85
264
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
1.9
13.0
191
873
T05
ICPC
Feeding problem of adult
3.8
12.9
54
121
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
2.6
12.9
92
301
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
2.6
12.9
92
301
SPAT1104
SPAT
Monitoring of emergency patient
1.5
12.9
522
3136
S82
ICPC
Naevus/mole
0.7
12.9
492
5825
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
0.4
12.9
60
1214
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
4.0
12.9
51
109
F00.22
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations
45.9
12.9
16
*
OAB43
SPAT
NA
0.4
12.9
49
1072
N06AA09
ATC
amitriptyline; systemic
1.4
12.8
725
4635
T89
ICPC
Diabetes insulin dependent
1.9
12.8
181
816
U28
ICPC
Limited function/disability (U)
2.5
12.8
104
365
F0230, G20
ICD-10 Finland
NA
+∞
12.8
13
*
F02.89*A69.2
ICD-10 Finland
Dementia in Lyme disease
+∞
12.8
13
*
F0203, G310
ICD-10 Finland
NA
+∞
12.8
13
*
F0021, G308
ICD-10 Finland
NA
+∞
12.8
13
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
12.7
1326
9264
A10AA02
ATC
NA
1.9
12.7
180
812
E0000UV
ATC
NA
1.2
12.7
2686
20262
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.2
12.7
2027
14873
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.5
12.6
482
2861
A86
ICD-10 Finland
Unspecified viral encephalitis
4.5
12.6
45
87
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.2
12.6
65
173
A10BA02
ATC
metformin; oral
1.2
12.6
2366
17643
J01DB01
ATC
cefalexin; oral
1.2
12.6
6166
50117
Y07
ICD-10 Finland
Other maltreatment
6.1
12.5
34
48
F01.33
ICD-10 Finland
Mixed cortical and subcortical vascular dementia other additional symptoms, mainly depression
29.2
12.5
17
5
N05AF05
ATC
zuclopenthixol; systemic
3.2
12.5
66
179
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
3.5
12.4
58
143
RT150
NOMESCO Finland
NA
11.6
12.4
23
17
Z01.8
ICD-10 Finland
Other specified special examinations
1.2
12.4
1535
10943
N05AL01
ATC
sulpiride; systemic
2.4
12.4
109
401
D17
ICPC
Incontinence of bowel
2.7
12.4
85
273
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.5
12.3
90
1562
L04AX07
ATC
dimethyl fumarate; oral
12.6
12.3
22
15
N07XX09
ATC
[U] dimethyl fumarate; oral
22.1
12.3
18
7
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
0.6
12.2
153
2279
Y94.1
ICD-10 Finland
Accident in connection with service housing
15.6
12.2
20
11
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.3
12.2
787
5144
WX111
NOMESCO Finland
Local infiltration anesthesia
0.5
12.1
89
1540
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
2.1
12.1
134
548
S22.4
ICD-10 Finland
Multiple fractures of ribs
2.0
12.1
152
655
188
Kela drug reimbursment
Psychosis requiring demanding treatment
3.5
12.0
56
138
G40.89
ICD-10 Finland
Other epilepsy
4.6
12.0
41
76
RS222
NOMESCO Finland
NA
2.5
11.9
93
321
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
1.8
11.9
199
952
R40.0
ICD-10 Finland
Somnolence
5.9
11.9
33
48
SPAT1285
SPAT
Provision of consultation response
1.5
11.9
418
2444
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
3.6
11.8
54
131
R1260
NOMESCO Finland
Evaluation of communicative skills
2.0
11.8
148
635
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
2.2
11.8
115
444
Z60.9
ICD-10 Finland
Problem related to social environment, unspecified
6.4
11.8
31
42
F02.00
ICD-10 Finland
Dementia in Pick's disease without additional symptoms
+∞
11.8
12
*
F0023, G308
ICD-10 Finland
NA
+∞
11.8
12
*
F0004, G300
ICD-10 Finland
NA
+∞
11.8
12
*
F0022, G308
ICD-10 Finland
NA
+∞
11.8
12
*
R47.0
ICD-10 Finland
Dysphasia and aphasia
2.5
11.6
88
299
Z72.1
ICD-10 Finland
Alcohol use
2.8
11.6
76
236
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.7
11.6
562
6416
XKD00
NOMESCO Finland
Uroflowmetry
1.2
11.6
1581
11384
SPAT1243
SPAT
Psychiatric/psychological examination
2.5
11.6
88
300
S00.8
ICD-10 Finland
Superficial injury of other parts of head
2.3
11.6
106
398
PJA12
NOMESCO Finland
Sentinel node biopsy
0.6
11.6
234
3116
WF002
NOMESCO Finland
Radical radiotherapy
0.6
11.6
205
2811
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
1.8
11.6
211
1040
N04BC02
ATC
pergolide; oral
9.9
11.5
23
20
N03AX11
ATC
topiramate; oral
2.5
11.5
90
311
K92.0
ICD-10 Finland
Haematemesis
1.9
11.5
176
817
R4130
NOMESCO Finland
Speech therapy
1.9
11.5
166
754
Z11
ICPC
Compliance/being ill problem
3.4
11.4
54
135
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.2
11.4
110
424
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
2.7
11.3
76
242
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
6.9
11.3
28
35
E16.19
ICD-10 Finland
Other specified hypoglycaemia
5.7
11.3
32
48
A05
ICPC
Feeling ill
1.6
11.3
273
1459
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
2.8
11.3
70
212
XF606
SPAT
NA
5.1
11.2
35
59
S32.8
ICD-10 Finland
Fracture of other and unspecified parts of lumbar spine and pelvis
2.7
11.2
78
254
G46.8*I67.9
ICD-10 Finland
Other vascular syndromes of brain in cerebrovascular diseases
6.4
11.1
29
39
S18
ICPC
Laceration/cut
0.8
11.1
2955
28137
Z43.5
ICD-10 Finland
Attention to cystostomy
3.1
11.1
60
166
SPAT1165
SPAT
Peritoneal dialysis
6.7
11.1
28
36
R4120
NOMESCO Finland
Occupational therapy
1.5
11.1
394
2307
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
3.4
11.1
53
134
P01
ICPC
Feeling anxious/nervous/tense
1.6
11.1
299
1642
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.1
11.1
123
506
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.3
11.1
731
4790
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.6
11.1
288
1569
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
2.1
11.1
120
488
N40
ICD-10 Finland
Hyperplasia of prostate
1.2
11.0
2155
16087
R01AD12
ATC
fluticasone furoate; nasal
0.8
11.0
992
10455
WZC30
NOMESCO Finland
Teaching
0.7
11.0
615
6878
W10
ICD-10 Finland
Fall on and from stairs and steps
1.5
11.0
326
1833
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
1.9
11.0
162
743
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
0.5
10.9
87
1468
G04BD10
ATC
darifenacin; oral
2.9
10.9
67
200
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
2.8
10.9
68
207
S42.0
ICD-10 Finland
Fracture of clavicle
1.9
10.9
158
722
F0200, G310
ICD-10 Finland
NA
+∞
10.8
11
*
F0024, G301
ICD-10 Finland
NA
+∞
10.8
11
*
F0204, G310
ICD-10 Finland
NA
+∞
10.8
11
*
F02.89*M32.8
ICD-10 Finland
Dementia in systemic lupus erythematosus
+∞
10.8
11
*
2900A
ICD-9 Finland
Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated
+∞
10.8
11
*
S06.9
ICD-10 Finland
Intracranial injury, unspecified
3.4
10.8
51
128
N06AG02
ATC
moclobemide; oral
1.6
10.8
290
1594
N07BB01
ATC
disulfiram; oral
1.8
10.8
182
875
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
3.3
10.8
54
142
S80.0
ICD-10 Finland
Contusion of knee
1.5
10.7
335
1907
SPAT1255
SPAT
Intravenous administration of medicine
1.4
10.7
497
3068
F00.0
ICD-10 Finland
Dementia in Alzheimer disease with early onset
103.2
10.7
12
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
10.7
1214
8554
F06.8
ICD-10 Finland
Other specified mental disorders due to brain damage and dysfunction and to physical disease
7.9
10.7
24
26
E16.0
ICD-10 Finland
Drug-induced hypoglycaemia without coma
3.8
10.7
45
103
F34.1
ICD-10 Finland
Dysthymia
1.9
10.6
151
684
NF3AA
NOMESCO Finland
Femur X-ray examination
1.9
10.5
143
638
L08
ICPC
Shoulder symptom/complaint
0.8
10.5
978
10271
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
3.3
10.5
52
136
F01.14
ICD-10 Finland
Multi-infarct dementia's other mixed symptoms of mixed type
30.1
10.4
14
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.8
10.4
1422
14356
F09
ICD-10 Finland
Unspecified organic or symptomatic mental disorder
11.7
10.4
19
14
N80
ICPC
Head injury other
2.1
10.3
121
508
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
2.7
10.3
69
220
JN4AD
NOMESCO Finland
Body CT examination
0.7
10.3
353
4253
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.4
10.2
548
3472
HA1RA
SPAT
NA
0.3
10.2
17
542
AA1CG
SPAT
NA
3.6
10.2
45
107
D64.9
ICD-10 Finland
Anaemia, unspecified
1.3
10.2
853
5780
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
2.7
10.2
70
227
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
10.1
10.2
20
17
P72
ICPC
Schizophrenia
2.5
10.2
76
258
SPAT1107
SPAT
Extensive external surface anaesthesia of skin with cream or gel
4.3
10.2
37
74
WF003
NOMESCO Finland
Adjuvant radiotherapy
0.5
10.2
96
1539
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
3.2
10.2
53
144
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
37.2
10.1
13
*
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.5
10.1
352
2054
N06AX05
ATC
trazodone; oral
2.0
10.1
127
550
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.8
10.1
42
95
D19
ICPC
Teeth/gum symptom/complaint
0.8
10.1
981
10260
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
1.9
10.1
151
697
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
5.5
10.1
29
45
N05AA01
ATC
chlorpromazine; systemic, rectal
2.6
10.0
72
240
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
2.5
9.9
77
266
A78
ICPC
Infectious disease other/NOS
2.4
9.9
81
289
A23
ICPC
Risk factor NOS
1.5
9.9
306
1737
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
2.0
9.9
129
565
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.0
9.9
121
520
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
1.5
9.9
344
2006
L03AA02
ATC
filgrastim; parenteral
0.5
9.8
55
1038
A10BH01
ATC
sitagliptin; oral
1.3
9.8
789
5319
F000, G300
ICD-10 Finland
NA
+∞
9.8
10
*
F02.3
ICD-10 Finland
Dementia in Parkinson disease
+∞
9.8
10
*
F02.89*M30.0
ICD-10 Finland
Dementia in polyarteritis nodosa
+∞
9.8
10
*
F0013, G301
ICD-10 Finland
NA
+∞
9.8
10
*
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
15.3
9.8
16
9
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
3.7
9.8
42
98
F02.8
ICD-10 Finland
Dementia in other specified diseases classified elsewhere
94.6
9.8
11
*
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
3.8
9.7
40
90
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
2.6
9.7
72
242
AA400
NOMESCO Finland
Electroconvulsive therapy
3.5
9.7
45
112
K59.1
ICD-10 Finland
Functional diarrhoea
1.5
9.7
356
2103
XX3DW
NOMESCO Finland
Time consuming IT work
0.7
9.6
472
5378
A41.9
ICD-10 Finland
Sepsis, unspecified
1.6
9.6
263
1453
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.8
9.6
1225
12465
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.4
9.6
515
3265
G04CB02
ATC
dutasteride; oral
1.3
9.6
636
4171
GD1AA
SPAT
NA
0.5
9.6
72
1235
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.4
9.6
465
2897
NG1AA
SPAT
NA
0.3
9.6
24
624
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
3.9
9.6
38
83
SPAT1111
SPAT
Planning of analgesia
2.3
9.6
87
328
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
1.9
9.5
128
569
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.5
9.5
374
2241
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.8
9.5
165
803
R54
ICD-10 Finland
Senility
4.8
9.5
31
56
A10AA01
ATC
NA
2.0
9.4
119
519
K28
ICPC
Limited function/disability (K)
1.7
9.4
185
936
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
4.7
9.3
31
57
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
3.9
9.3
37
81
R51.80
ICD-10 Finland
Headache
1.3
9.3
749
5051
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
5.2
9.3
28
46
F61.0
ICD-10 Finland
Mixed personality disorders
2.9
9.3
54
158
N05BA12
ATC
alprazolam; oral
1.3
9.3
596
3888
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.3
9.3
690
4603
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
1.8
9.3
167
823
A04AA55
ATC
palonosetron, combinations; systemic
0.4
9.3
29
687
G93.4
ICD-10 Finland
Encephalopathy, unspecified
5.0
9.3
29
50
N07
ICPC
Convulsion/seizure
6.0
9.3
25
36
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
0.7
9.2
260
3241
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.5
9.2
280
1584
G81.9
ICD-10 Finland
Hemiplegia, unspecified
2.5
9.2
69
234
SPAT1236
SPAT
Informing family of child’s disability
1.8
9.2
166
818
F31.8
ICD-10 Finland
Other bipolar affective disorders
2.8
9.2
58
179
G40.10
ICD-10 Finland
Simple partial seizures
2.9
9.2
54
160
N04BC06
ATC
cabergoline; oral (dopamine agonists)
4.2
9.2
34
70
N05AF01
ATC
flupentixol; systemic
2.0
9.2
108
456
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
2.8
9.1
57
174
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.3
9.1
693
4636
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
1.5
9.1
283
1612
DFF00
NOMESCO Finland
Pure tone audiometry
0.7
9.1
430
4925
D07AA02
ATC
hydrocortisone; topical
1.3
9.1
732
4941
T08
ICPC
Weight loss
2.0
9.1
110
472
F07.8
ICD-10 Finland
Other organic personality and behavioural disorders due to brain disease, damage and dysfunction
9.7
9.1
18
16
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.6
9.1
105
1588
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
2.6
9.0
65
217
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
4.2
9.0
33
67
SPAT1058
SPAT
PEF monitoring instruction
0.7
9.0
361
4239
F06.32
ICD-10 Finland
Organic depression
6.1
9.0
24
34
G41.0
ICD-10 Finland
Grand mal status epilepticus
6.1
9.0
24
34
P18
ICPC
Medication abuse
5.0
9.0
28
48
I50.0
ICD-10 Finland
Congestive heart failure
1.3
9.0
586
3833
IHZ08
SPAT
NA
17.2
9.0
14
7
T68
ICD-10 Finland
Hypothermia
3.6
9.0
40
97
C09AA05
ATC
ramipril; oral
1.2
9.0
2222
16886
SPAT1042
SPAT
Guidance concerning balance maintenance
2.7
9.0
58
183
N05CD02
ATC
nitrazepam; oral
1.9
8.9
124
560
QAB00
NOMESCO Finland
Suture of skin of head or neck
2.2
8.9
88
346
3400A
ICD-9 Finland
Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]
5.7
8.9
25
38
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.2
8.9
1740
12954
115
Kela drug reimbursment
Breast cancer
0.7
8.9
271
3327
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
3.7
8.9
37
85
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
1.8
8.8
143
682
2912A
ICD-9 Finland
Alcoholic psychoses, Other alcoholic dementia
+∞
8.8
9
*
F0234, G20
ICD-10 Finland
NA
+∞
8.8
9
*
F0021, G301
ICD-10 Finland
NA
+∞
8.8
9
*
F00.02
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions
+∞
8.8
9
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
0.5
8.8
49
926
WYA30
SPAT
NA
3.4
8.8
41
103
Q90.9
ICD-10 Finland
Down syndrome, unspecified
86.0
8.8
10
*
F01.81
ICD-10 Finland
Other specified vascular dementia has other additional symptoms, mainly paranoidism
86.0
8.8
10
*
CBB11
NOMESCO Finland
Resection of lax skin in upper eyelid
0.5
8.8
60
1059
A10BH05
ATC
linagliptin; oral
1.4
8.8
425
2646
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
3.0
8.7
50
145
I68.0
ICD-10 Finland
Cerebral amyloid angiopathy
8.2
8.7
19
20
D11
ICPC
Diarrhoea
1.3
8.7
535
3469
AA1AD
SPAT
NA
4.8
8.7
28
50
ZXC96
NOMESCO Finland
Robot assisted procedure
0.5
8.7
56
1007
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
5.2
8.7
26
43
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
4.2
8.6
32
66
S32.5
ICD-10 Finland
Fracture of pubis
2.6
8.6
62
207
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
0.3
8.6
21
554
R74
ICPC
Upper respiratory infection acute
0.8
8.6
850
8881
AA1XD
NOMESCO Finland
Other special CT of head and brain
3.3
8.6
42
110
EBA00
NOMESCO Finland
Extraction of tooth
1.2
8.5
2084
15807
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.1
8.5
99
416
N05BA02
ATC
chlordiazepoxide; systemic
1.8
8.5
153
755
G91.1
ICD-10 Finland
Obstructive hydrocephalus
4.1
8.5
32
67
Z20.8
ICD-10 Finland
Contact with and exposure to other communicable diseases
1.6
8.5
204
1093
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
5.1
8.5
26
44
R07.4
ICD-10 Finland
Chest pain, unspecified
1.2
8.5
2129
16182
R39.1
ICD-10 Finland
Other difficulties with micturition
1.6
8.4
225
1236
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
1.8
8.4
143
693
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
1.8
8.4
148
723
R26
ICD-10 Finland
Abnormalities of gait and mobility
3.9
8.4
33
72
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
2.0
8.4
98
413
F01.22
ICD-10 Finland
Subcortical vascular dementia with additional symptoms, mainly hallucinations
31.5
8.4
11
*
NB6AA
NOMESCO Finland
Humerus X-ray examination
1.8
8.4
140
673
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.3
8.4
656
4411
A01AB09
ATC
miconazole; local oral
1.3
8.3
593
3933
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.2
8.3
2208
16855
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
1.7
8.3
153
761
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
0.7
8.3
327
3851
IGV01
NOMESCO Finland
Psychiatric network contact
4.7
8.3
27
49
F22.8
ICD-10 Finland
Other persistent delusional disorders
6.4
8.3
21
28
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
3.3
8.3
40
104
HA1RA
NOMESCO Finland
Combined assessment of mammary gland (mammography and ultrasound)
0.3
8.2
15
456
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.3
8.2
513
3333
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
0.6
8.2
124
1756
R4150
NOMESCO Finland
Neuropsychological rehabilitation
3.8
8.2
34
78
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
0.5
8.2
77
1233
XCK10
NOMESCO Finland
Photography of fundus of eye
1.3
8.2
809
5603
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
5.3
8.2
24
39
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.3
8.1
725
4955
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
0.4
8.1
37
750
R47.1
ICD-10 Finland
Dysarthria and anarthria
2.3
8.1
75
287
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.5
8.1
289
1698
C01DA14
ATC
isosorbide mononitrate; oral
1.2
8.1
1454
10731
F01.13
ICD-10 Finland
The other additional symptoms of multi-infarct dementia, mainly depression
43.0
8.1
10
*
L02BG04
ATC
letrozole; oral
0.6
8.1
173
2272
G02CB01
ATC
bromocriptine; systemic
2.8
8.1
51
158
Z59.8
ICD-10 Finland
Other problems related to housing and economic circumstances
7.7
8.0
18
20
Z74.0
ICD-10 Finland
Need for assistance due to reduced mobility
7.7
8.0
18
20
ACC51
NOMESCO Finland
Release of median nerve
0.7
8.0
209
2641
N06AA12
ATC
doxepin; systemic
1.4
8.0
357
2192
N03AX16
ATC
pregabalin; oral
1.2
8.0
1636
12214
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
4.1
8.0
30
63
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
5.7
8.0
22
33
N06AB05
ATC
paroxetine; oral
1.5
8.0
277
1619
359
Kela drug reimbursment
Mirabegroni
2.5
8.0
62
218
A02BC01
ATC
omeprazole; systemic
1.2
7.9
2058
15674
RS121
NOMESCO Finland
NA
3.0
7.9
43
122
P04
ICPC
Feeling/behaving irritable/angry
4.7
7.9
26
48
F10.7
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Residual and late-onset psychotic disorder
12.0
7.9
14
10
Z93.5
ICD-10 Finland
Cystostomy status
4.3
7.9
28
56
F01.32
ICD-10 Finland
Mixed cortical and subcortical vascular dementia other additional symptoms, mainly hallucinations
+∞
7.9
8
*
F0282, G318
ICD-10 Finland
NA
+∞
7.9
8
*
F01.11
ICD-10 Finland
The other additional symptoms of multi-infarct dementia, mainly paranoidism
+∞
7.9
8
*
F02.29*G10
ICD-10 Finland
Dementia in Huntington's disease without information on additional symptoms
+∞
7.9
8
*
SPAT1277
SPAT
Instruction concerning legal protection and patient’s rights
5.0
7.8
24
41
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
7.4
7.8
18
21
F07.0
ICD-10 Finland
Organic personality disorder
14.0
7.8
13
8
L03AA13
ATC
pegfilgrastim; parenteral
0.6
7.8
90
1360
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
1.6
7.8
204
1117
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
4.8
7.8
25
45
F06.33
ICD-10 Finland
Organic mood syndrome
17.2
7.8
12
6
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
0.5
7.8
75
1190
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
2.2
7.7
74
286
Z50.5
ICD-10 Finland
Speech therapy
2.2
7.7
79
315
R31
ICD-10 Finland
Unspecified haematuria
1.2
7.7
853
5985
S01.3
ICD-10 Finland
Open wound of ear
2.2
7.7
75
295
G72.9
ICD-10 Finland
Myopathy, unspecified
2.5
7.7
57
195
A08
ICPC
Swelling
1.4
7.7
320
1943
N03AX15
ATC
zonisamide; oral
8.6
7.6
16
16
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
4.0
7.6
29
62
P16
ICPC
Acute alcohol abuse
2.4
7.6
65
238
R60.9
ICD-10 Finland
Oedema, unspecified
1.4
7.6
347
2142
S15
ICPC
Foreign body in skin
0.7
7.6
241
2939
ZXA00
NOMESCO Finland
Right side
1.2
7.6
2134
16346
X58
ICD-10 Finland
Exposure to other specified factors
1.3
7.6
704
4841
H3601, E113
ICD-10 Finland
NA
1.8
7.6
120
569
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.2
7.5
1215
8871
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
1.7
7.5
156
805
Z46.9
ICD-10 Finland
Fitting and adjustment of unspecified device
1.9
7.5
100
445
HMAK
NOMESCO Finland
NA
0.7
7.5
397
4476
M70.6
ICD-10 Finland
Trochanteric bursitis
0.8
7.5
589
6318
F31
ICD-10 Finland
Bipolar affective disorder
2.8
7.5
46
142
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
3.1
7.5
39
108
F91.9
ICD-10 Finland
Conduct disorder, unspecified
28.6
7.5
10
*
C07AB02
ATC
metoprolol; systemic
1.2
7.5
1786
13506
S72.2
ICD-10 Finland
Subtrochanteric fracture
2.5
7.5
56
194
S20
ICPC
Corn/callosity
1.7
7.5
157
815
J01FA10
ATC
azithromycin; systemic
0.9
7.4
2834
26528
C10AA07
ATC
rosuvastatin; oral
0.9
7.4
1560
15233
NFB10
NOMESCO Finland
Primary partial prosthetic replacement of hip joint not using cement, other or unspecified
3.9
7.4
29
64
N43
ICPC
Neurological, Other diagnostic procedure
2.7
7.4
48
153
NBJ62
NOMESCO Finland
Internal fixation of fracture of shoulder or upper arm using plate and screws, humerus
2.0
7.4
86
364
F10.74
ICD-10 Finland
Residual or late-onset psychosis caused by alcohol otherwise permanently impaired intelligence
14.7
7.4
12
7
D82
ICPC
Teeth/gum disease
0.8
7.4
1445
14189
SPAT1244
SPAT
Occupational therapy
2.1
7.4
82
342
Z74.2
ICD-10 Finland
Need for assistance at home and no other household member able to render care
18.9
7.4
11
5
OAA80
SPAT
NA
0.2
7.3
5
267
N06AA06
ATC
trimipramine; systemic
1.7
7.3
145
736
D06BB10
ATC
imiquimod; topical
0.6
7.3
153
2015
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
2.1
7.3
76
306
OAB48
SPAT
NA
0.4
7.3
23
541
C10AA02
ATC
lovastatin; oral
1.4
7.3
371
2335
RS230
NOMESCO Finland
NA
3.4
7.3
34
87
SPAT1062
SPAT
Lung clearance therapy
3.8
7.3
29
65
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
3.8
7.3
29
65
P27
ICPC
Fear of mental disorder
2.8
7.3
44
135
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
1.7
7.2
146
747
F02.82
ICD-10 Finland
Dementia in other specified disease that is classified elsewhere other symptoms, mainly hallucinations
38.6
7.2
9
*
F01.31
ICD-10 Finland
Mixed cortical and subcortical vascular dementia other additional symptoms, mainly paranoidism
38.6
7.2
9
*
F02.04
ICD-10 Finland
Dementia in Pick's disease other additional symptoms of mixed type
38.6
7.2
9
*
AAF15
NOMESCO Finland
Ventriculoatrial shunt
3.9
7.1
28
62
L15
ICPC
Knee symptom/complaint
0.8
7.1
1131
11308
F41.1
ICD-10 Finland
Generalized anxiety disorder
1.8
7.1
120
582
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
0.7
7.1
227
2765
E55.9
ICD-10 Finland
Vitamin D deficiency, unspecified
3.3
7.1
34
89
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
3.7
7.1
29
67
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
4.9
7.0
22
39
G25.1
ICD-10 Finland
Drug-induced tremor
4.9
7.0
22
39
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
2.8
7.0
42
128
AAF00
NOMESCO Finland
Ventriculostomy
2.7
7.0
45
142
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
0.6
7.0
139
1851
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
4.2
7.0
25
51
K92.1
ICD-10 Finland
Melaena
1.4
7.0
398
2557
A41.8
ICD-10 Finland
Other specified sepsis
1.7
6.9
126
627
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.5
6.9
234
1364
G40.36
ICD-10 Finland
Juvenile myoclonic epilepsy [impulsive petit mal]
68.8
6.9
8
*
F01.12
ICD-10 Finland
The other additional symptoms of multi-infarct dementia, mainly hallucinations
68.8
6.9
8
*
SPAT1109
SPAT
Analgesia with portable analgesic pump
2.5
6.9
52
180
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.3
6.9
558
3766
WX302
NOMESCO Finland
Thoracal epidural anesthesy
0.7
6.9
187
2343
81
HP
Angiography of the heart and coronary arteries
1.3
6.9
595
4051
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.3
6.9
521
3489
F02.89*T58
ICD-10 Finland
Dementia with carbon monoxide intoxication
+∞
6.9
7
*
65000
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
0.8
6.9
1163
11565
E000003
ATC
NA
1.5
6.9
240
1408
C07AB07
ATC
bisoprolol; oral
1.1
6.9
4208
33913
E44.1
ICD-10 Finland
Mild protein-energy malnutrition
10.2
6.9
13
11
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
1.6
6.8
183
1013
C10AA05
ATC
atorvastatin; oral
1.1
6.8
3478
27704
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
5.2
6.8
20
33
C09CA06
ATC
candesartan; oral
0.8
6.8
1111
11080
A34
ICPC
General and Unspecified, Blood test
1.9
6.8
90
402
R82.7
ICD-10 Finland
Abnormal findings on microbiological examination of urine
3.8
6.8
27
61
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.9
6.8
2576
24156
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
1.9
6.8
92
415
SPAT1313
SPAT
Guidance and counselling related to accident prevention
2.4
6.8
52
184
Z08
ICPC
Social welfare problem
2.3
6.7
62
237
S42.4
ICD-10 Finland
Fracture of lower end of humerus
2.1
6.7
68
274
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
0.3
6.7
19
465
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
2.5
6.7
51
179
H25.1
ICD-10 Finland
Senile nuclear cataract
1.1
6.7
2583
20204
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
0.9
6.7
1849
17714
N06AA04
ATC
clomipramine; systemic
1.9
6.7
97
448
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.3
6.6
424
2769
Z50.1
ICD-10 Finland
Other physical therapy
1.4
6.6
376
2413
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
3.3
6.6
31
80
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
3.5
6.6
29
71
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
0.7
6.6
194
2395
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
1.8
6.6
105
502
30040
ICD-8 Finland
Neuroses, Neurotico-depressiva
2.4
6.6
54
197
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.9
6.6
2959
27481
SPAT1352
SPAT
Inspection, maintenance and instruction for use of hearing aid
1.7
6.6
119
591
A04AD12
ATC
aprepitant; systemic
0.4
6.6
25
543
N30
ICD-10 Finland
Cystitis
1.3
6.6
406
2640
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.1
6.6
73
304
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.3
6.6
452
2985
S22
ICPC
Nail symptom/complaint
1.3
6.6
398
2582
Z51.4
ICD-10 Finland
Preparatory care for subsequent treatment, not elsewhere classified
2.2
6.5
61
236
T93
ICPC
Lipid disorder
0.7
6.5
230
2754
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.5
6.5
39
716
NFJ62
NOMESCO Finland
Internal fixation of fracture of other parts of femur with plate
2.3
6.5
56
210
F61
ICD-10 Finland
Mixed and other personality disorders
4.6
6.5
21
39
I67.2
ICD-10 Finland
Cerebral atherosclerosis
3.0
6.5
34
96
G21.8
ICD-10 Finland
Other secondary parkinsonism
4.4
6.5
22
43
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
1.7
6.5
123
620
F32.8
ICD-10 Finland
Other depressive episodes
2.3
6.5
58
221
A10BX01
ATC
guar gum; systemic
1.4
6.5
309
1927
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
0.7
6.5
172
2160
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
0.1
6.5
*
166
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
1.4
6.4
333
2103
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
1.4
6.4
298
1849
L89
ICPC
Osteoarthrosis of hip
0.6
6.4
130
1723
HA1AA
SPAT
NA
0.3
6.4
10
325
DJA10
NOMESCO Finland
Biopsy of septum of nose
5.8
6.4
17
25
A02BC03
ATC
lansoprazole; oral
1.1
6.4
2121
16409
U29
ICPC
Urinary symptom/complaint other
1.5
6.4
202
1161
Z27
ICPC
Fear of a social problem
4.0
6.4
24
52
H3600, E113
ICD-10 Finland
NA
1.8
6.4
104
501
F30.1
ICD-10 Finland
Mania without psychotic symptoms
6.3
6.3
16
22
S12
ICPC
Insect bite/sting
0.8
6.3
363
4046
I63.8
ICD-10 Finland
Other cerebral infarction
2.1
6.3
69
285
SPAT1241
SPAT
Extensive assessment of psychosocial situation
2.7
6.3
41
131
I69
ICD-10 Finland
Sequelae of cerebrovascular disease
3.0
6.3
36
105
L03AA14
ATC
lipegfilgrastim; parenteral
0.4
6.3
23
508
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
2.3
6.3
54
201
D10
ICPC
Vomiting
1.6
6.3
158
860
N06AX18
ATC
reboxetine; oral
2.2
6.3
59
228
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
1.8
6.3
94
439
B99
ICD-10 Finland
Other and unspecified infectious diseases
1.7
6.3
130
672
NF1AA
SPAT
NA
0.3
6.3
13
366
P12
ICPC
Bedwetting/enuresis
34.3
6.3
8
*
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
3.8
6.3
25
57
OAA65
SPAT
NA
0.4
6.3
28
569
XCH00
NOMESCO Finland
Eye pressure measurement
0.7
6.3
163
2054
S30.1
ICD-10 Finland
Contusion of abdominal wall
2.0
6.3
76
331
A10BB07
ATC
glipizide; oral
1.8
6.2
98
468
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.1
6.2
64
260
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
4.2
6.2
22
45
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.3
6.2
17
421
KE1DG
NOMESCO Finland
Very extensive MRI of prostate
0.2
6.2
7
274
E53.8
ICD-10 Finland
Deficiency of other specified B group vitamins
2.5
6.2
44
149
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.4
6.2
314
1979
A07
ICPC
Coma
3.1
6.2
32
90
HAB40
NOMESCO Finland
Wedge excision of mammary gland
0.7
6.2
156
1975
I67.4
ICD-10 Finland
Hypertensive encephalopathy
6.0
6.2
16
23
W18
ICD-10 Finland
Other fall on same level
3.7
6.2
25
58
A81.0
ICD-10 Finland
Creutzfeldt-Jakob disease
19.3
6.2
9
*
FN1CB
NOMESCO Finland
Coronary flow reserve measurement with pressure wire
0.5
6.1
60
944
G21.0
ICD-10 Finland
Malignant neuroleptic syndrome
9.4
6.1
12
11
TFP44
NOMESCO Finland
Ablation treatment of typical atrial flutter
0.2
6.1
8
286
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
1.8
6.1
100
482
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.8
6.1
385
4238
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
4.1
6.1
22
46
A69.2
ICD-10 Finland
Lyme disease
0.7
6.1
159
2004
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
4.3
6.1
21
42
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
2.8
6.1
36
110
J01MA12
ATC
levofloxacin; systemic
1.2
6.0
1366
10273
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
2.1
6.0
60
241
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
802
427
13.84
307.65
1.0
1.0
ng/l
53.4
38.0
9.11
586
246
(3019309) Folate [Moles/volume] in Red Blood Cells
6578
23942
2.54
307.65
2.0
1.8
nmol/l
1189.4
1155.2
1.98
4801
17645
(3009466) Valproate [Moles/volume] in Serum or Plasma
669
804
6.06
307.65
3.9
3.8
umol/l
328.5
337.8
0.69
533
677
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
791
430
13.55
307.65
1.0
1.0
ng/l
395.5
289.3
7.94
588
254
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
801
426
13.86
307.65
1.0
1.0
ng/l
575.9
759.9
11.67
578
244
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
923
1599
4.24
300.65
1.2
1.3
mg/l
507.3
570.0
1.12
838
1521
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
827
1358
4.46
287.43
1.2
1.4
e6/l
8.9
21.6
1.27
654
1066
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
826
1359
4.45
286.40
1.3
1.4
e6/l
337.3
1166.4
3.56
673
1126
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
822
1389
4.33
275.80
1.2
1.2
mmol/l
3.9
3.8
0.59
765
1296
(3044290) Cell count panel - Cerebral spinal fluid
714
1267
4.10
224.76
1.2
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
9723
81585
0.62
178.60
4.0
4.8
mmol/l
1.4
1.4
4.65
8258
72206
(3026008) Bacteria identified in Urine by Culture
6823
35314
1.61
174.22
4.2
3.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
3502
37259
0.57
172.75
2.2
2.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
9918
82468
0.63
167.69
4.0
4.9
mmol/l
4.3
4.4
17.10
8478
73659
(3023368) Bacteria identified in Blood by Culture
6228
31952
1.59
161.32
4.3
4.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1800
22844
0.50
159.27
1.5
1.6
mmol/l
1.2
1.3
1.03
1518
18583
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
4831
23352
1.64
159.05
1.8
1.8
pmol/l
434.6
26089988.5
12.95
3820
18448
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
9424
78885
0.64
157.75
3.6
4.3
mmol/l
1.2
1.2
1.81
7897
69008
(3023410) Appearance of Cerebral spinal fluid
382
562
4.88
150.03
1.3
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
10455
85106
0.65
144.78
4.6
5.6
mmol/l
2.4
2.5
19.07
8981
75743
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
4318
20934
1.61
136.44
3.0
3.1
mmol/l
2.5
2.5
5.47
3671
18011
(3015377) Calcium [Moles/volume] in Serum or Plasma
6548
35154
1.51
130.11
2.5
3.3
mmol/l
2.3
2.4
2.40
5410
29535
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
8133
45726
1.49
128.65
2.5
2.2
pmol/l
89.5
93.2
9.93
4365
23447
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1734
6629
1.94
123.94
1.6
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
3252
32513
0.63
109.28
2.8
3.2
mg/l
567.7
384.3
1.17
2041
20713
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
3915
19497
1.54
105.39
2.0
1.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
3304
32691
0.64
104.66
2.7
3.1
mmol/l
6.9
6.8
0.86
2538
26575
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
10019
80586
0.69
103.99
21.2
18.1
ml/min/173m2
68.5
69.1
1.95
8052
67277
(3020682) Albumin/Creatinine [Ratio] in Urine
3549
34425
0.65
101.43
3.4
4.0
mg/mmol
14.0
9.9
2.56
2196
21619
(3031040) Bacteria [#/volume] in Urine by Automated count
10709
65199
1.43
98.38
6.6
5.3
e6/l
3248.9
1206.0
2.69
338
1041
(3021960) Folate [Moles/volume] in Serum or Plasma
5188
27835
1.45
95.10
1.7
1.6
nmol/l
19.8
20.3
1.28
4534
23278
(3024561) Albumin [Mass/volume] in Serum or Plasma
7892
45820
1.40
92.33
3.9
4.5
g/l
33.9
34.2
4.74
6994
41955
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
2816
13422
1.57
90.12
1.9
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
2788
13500
1.55
82.44
1.9
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
311
665
3.34
75.06
1.2
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
5710
32194
1.38
74.19
2.4
2.1
u/l
272.6
215.5
4.26
5279
29850
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
10834
84467
0.73
73.47
4.7
5.4
mmol/l
6.2
6.1
11.40
9197
74304
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
982
12166
0.54
72.73
1.2
1.2
u/ml
11.6
15.9
0.99
272
4001
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1106
12989
0.57
67.15
1.2
1.3
iu/ml
47.7
41.9
0.44
323
3943
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
10453
81576
0.74
66.92
6.6
6.9
mmol/mol
42.7
41.2
32.16
9080
73238
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
7084
41920
1.33
64.17
5.0
4.4
ng/l
90.5
82.9
0.10
5737
33412
(4035726)
671
8989
0.51
63.60
1.3
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
2152
21340
0.67
61.82
3.4
3.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
916
3549
1.87
61.38
1.2
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
1170
13005
0.61
56.27
1.4
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
8757
53951
1.30
56.15
5.6
6.6
mmol/l
1.2
1.2
14.03
7078
44893
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
567
7577
0.51
52.84
1.3
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
6422
38175
1.30
52.74
2.2
2.2
nmol/l
77.6
80.8
13.06
5372
32774
(3019150) Specific gravity of Urine by Refractometry
3690
20388
1.35
50.20
5.5
4.8
kg/l
1.0
1.0
0.49
613
3351
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
7964
48871
1.28
50.18
5.0
5.9
mmol/l
1.2
1.2
2.42
6974
43588
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
231
577
2.85
43.27
2.4
2.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
610
7458
0.56
41.70
1.5
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
4960
29196
1.28
41.06
2.4
2.4
mg/l
3.1
3.2
0.23
3999
24646
(3018418) pH of Serum or Plasma
5379
32106
1.27
39.30
3.2
4.1
ph
7.4
7.4
0.68
927
6103
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1663
8339
1.45
39.09
1.7
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
926
10027
0.63
38.70
1.3
1.3
titre
506.0
524.9
0.13
197
2337
(3022145) Colonoscopy Study observation
936
10090
0.63
38.31
1.3
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
285
846
2.40
38.06
3.5
3.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
2315
21093
0.74
37.56
1.3
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
514
1935
1.90
37.49
1.9
2.1
umol/l
28.4
33.0
3.88
387
1550
(3026493) Urate [Moles/volume] in Serum or Plasma
2988
26075
0.77
35.21
2.4
3.0
umol/l
9263.8
6796.1
1.36
2342
21699
(3000492) Spirometry study
548
6595
0.57
35.15
1.5
1.6
—
—
—
0
0
(3015736) pH of Urine
5925
36162
1.24
34.25
4.6
4.0
—
5.7
—
0
30
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
5649
34335
1.24
33.80
5.6
4.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
108
2360
0.32
33.55
1.5
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
1353
13146
0.70
32.19
1.2
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1291
12637
0.70
32.04
4.1
5.0
%
34.4
34.0
0.54
717
8086
(3021589) Normoblasts [#/volume] in Blood
4847
39617
0.81
31.98
10.8
10.8
e9/l
0.0
0.0
1.46
3923
32138
(3029937) Albumin [Presence] in Urine by Test strip
4267
25264
1.25
31.86
5.4
4.7
estimate
0.0
0.0
1.73
1093
8167
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
680
7565
0.62
31.72
1.3
1.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
131
283
3.28
31.37
1.2
1.2
%
41.7
64.4
—
6
38
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1105
5333
1.49
31.30
1.8
1.5
%
1.7
1.6
0.65
891
4321
(3024354) Oxygen [Partial pressure] in Venous blood
1745
9191
1.38
30.62
3.1
3.1
kpa
4.2
4.4
4.28
1663
8860
(4010399)
607
6880
0.61
30.61
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
624
2652
1.68
30.37
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
623
2652
1.68
30.14
1.4
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
5532
44413
0.82
30.02
4.1
4.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
12105
90121
0.81
29.83
10.0
11.7
u/l
22.4
23.7
3.80
11251
85896
(3006270) Folate [Moles/volume] in Blood
282
946
2.12
28.38
1.3
1.2
nmol/l
305.9
310.7
0.13
211
703
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
123
273
3.19
28.28
3.1
2.7
umol/l
29.0
29.3
0.13
89
208
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
48
1501
0.22
28.18
1.4
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
8351
64274
0.83
28.15
4.6
4.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
3040
17557
1.27
27.40
30.0
32.5
inr
1.6
1.5
2.37
292
2360
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
6047
37640
1.21
26.75
2.6
2.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
9115
59017
1.19
25.72
5.0
4.8
mmol/l
7.2
6.9
18.09
8577
55538
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
231
760
2.16
24.48
1.3
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
504
5652
0.62
24.18
1.2
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
1441
7644
1.36
23.92
1.9
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1362
12648
0.74
23.91
2.6
3.8
ug/l
20.3
21.9
0.10
1115
10560
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
169
493
2.43
23.62
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
48
1336
0.25
23.33
1.2
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
7152
45570
1.18
23.30
5.0
4.2
estimate
0.0
0.0
0.00
1209
8629
(3026782) Osmolality of Urine
3696
22159
1.22
23.25
3.5
2.9
mosm/kgh2o
561.4
542.2
6.97
3152
18746
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
82
159
3.65
23.14
15.9
10.7
mmol/l
0.7
0.6
0.64
74
145
(3037467) Urinalysis macro (dipstick) panel - Urine
10014
65716
1.18
22.66
5.7
5.0
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1997
11187
1.29
22.56
3.2
3.6
kpa
5.8
5.8
0.34
1914
10835
(3008152) Bicarbonate [Moles/volume] in Arterial blood
1404
7485
1.35
22.52
5.2
6.5
mmol/l
24.6
24.6
0.10
1331
6966
(40768443) Skin Pathology biopsy report
404
4695
0.60
22.47
1.2
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
806
3912
1.47
22.12
2.1
2.2
ug/l
920.5
525.5
0.79
738
3705
(3002032) Base excess in Venous blood by calculation
1987
11162
1.29
21.93
3.2
3.6
mmol/l
2.1
1.9
0.90
1627
8971
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
181
564
2.27
21.90
1.2
1.2
mmol/l
2.0
2.3
3.57
165
512
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
69
123
3.96
21.82
11.6
10.7
nmol/l
649.6
820.5
2.22
64
117
(3002179) Metamyelocytes/100 leukocytes in Blood
757
7600
0.69
21.21
3.0
3.7
%
0.8
0.6
0.51
152
1845
(3002582) Erythrocytes [#/volume] in Urine
5245
32783
1.18
20.64
4.0
3.5
e6/l
112.3
114.5
0.03
4171
25551
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
2536
21406
0.81
20.61
2.9
3.5
ug/l
0.9
0.9
0.06
1793
15877
(4094501)
143
2226
0.45
20.61
1.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1965
11110
1.28
20.53
2.6
2.5
ug/l
5.3
6.3
2.06
1403
9441
(40761535) Cells panel - Urine sediment
1648
9121
1.30
20.29
3.9
3.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1552
13849
0.77
20.20
1.5
1.5
g/l
2.8
2.7
0.82
774
7506
(3012544) pH of Venous blood
2033
11569
1.27
20.13
3.2
3.6
ph
7.4
7.4
—
9
61
(3024891) Influenza virus A+B Ag [Presence] in Specimen
465
2042
1.62
20.03
1.3
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
7180
46150
1.17
19.80
5.1
4.3
estimate
0.0
0.0
1.34
1195
8500
(3017181) Myelocytes/100 leukocytes in Blood
879
8435
0.72
18.86
3.2
3.8
%
1.1
0.9
0.46
248
2606
(3052592) Norovirus Ag [Presence] in Stool
97
241
2.85
18.63
1.4
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
798
7757
0.71
18.51
3.2
2.9
ml/min/173m2
58.2
56.7
0.59
345
3540
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
1073
5653
1.36
18.51
4.2
4.2
%
46.1
46.2
0.04
1064
5579
(3018095) Leukocytes [#/volume] in Urine
5806
36837
1.17
18.48
4.6
4.0
e6/l
178.5
128.3
1.56
4348
27124
(3028707) Methadone [Presence] in Urine by Screen method
79
175
3.19
18.39
2.0
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
832
8020
0.72
18.34
3.2
3.8
%
0.1
0.1
0.07
227
2436
(4027681)
92
224
2.90
18.31
1.2
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
7065
45564
1.16
18.01
6.7
5.7
estimate
0.0
0.0
0.80
1189
8650
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2974
24368
0.83
17.47
2.3
2.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
767
7428
0.71
17.38
3.3
3.8
%
0.1
0.4
2.60
181
2037
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
339
3821
0.62
16.63
3.2
3.9
u/ml
171.3
93.5
0.85
319
3643
(3006315) Basophils [#/volume] in Blood
5934
45818
0.86
16.50
4.9
5.4
e9/l
0.0
0.0
3.27
4995
38594
(3019832) Treponema pallidum Ab [Presence] in Serum
418
1878
1.58
16.46
1.2
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
6968
53177
0.87
16.37
6.8
8.4
e9/l
4.8
4.4
26.31
5942
45729
(3001604) Monocytes [#/volume] in Blood
5892
45500
0.87
16.36
4.9
5.4
e9/l
0.6
0.6
0.77
4950
38269
(3013115) Eosinophils [#/volume] in Blood
6116
47098
0.87
16.32
5.1
5.5
e9/l
0.2
0.2
0.50
5136
40258
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
111
318
2.47
16.28
2.7
2.0
umol/l
66.0
55.6
2.04
76
237
(40768793) Breast Pathology biopsy report
124
1859
0.47
16.22
1.2
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
397
1786
1.58
15.57
2.9
2.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
1153
10347
0.77
15.44
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
165
2175
0.53
14.63
1.2
1.2
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
54
109
3.50
14.54
1.1
1.1
%
24.1
50.2
2.35
16
48
(3040151) Glucose [Moles/volume] in Capillary blood
324
1413
1.63
14.47
8.9
13.0
mmol/l
7.8
7.3
1.16
257
1164
(3027273) Bicarbonate [Moles/volume] in Venous blood
1118
6141
1.30
14.46
3.4
3.4
mmol/l
25.4
25.1
1.73
1084
5969
(3019069) Monocytes/100 leukocytes in Blood
5615
43239
0.87
14.32
5.5
6.0
%
8.9
9.0
1.57
5064
39749
(3006504) Eosinophils/100 leukocytes in Blood
5586
43023
0.87
14.26
5.2
5.7
%
2.7
2.8
1.67
5030
39443
(3018010) Neutrophils/100 leukocytes in Blood
5597
43098
0.87
14.24
5.3
5.7
%
61.3
59.3
25.62
5038
39544
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
112
345
2.30
14.10
1.1
1.1
mg/l
37.5
45.4
1.37
89
294
(40768800) Prostate Pathology biopsy report
206
2517
0.57
14.01
1.2
1.2
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
76
195
2.75
13.89
1.3
1.2
%
49.6
22.0
—
5
27
(3005322) IgE [Units/volume] in Serum or Plasma
358
3828
0.65
13.86
1.3
1.3
u/ml
249.2
256.0
0.06
317
3473
(3022096) Basophils/100 leukocytes in Blood
5443
41919
0.87
13.71
5.2
5.7
%
0.6
0.6
11.60
4901
38484
(3043409) Potassium [Moles/volume] in Arterial blood
693
3579
1.38
13.57
3.2
4.0
mmol/l
3.9
3.9
0.82
613
3348
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
928
5016
1.32
13.49
4.0
4.6
%
1.6
1.6
0.78
886
4713
(3020564) Creatinine [Moles/volume] in Serum or Plasma
12336
90098
0.87
13.46
24.6
22.4
umol/l
86.7
86.2
0.63
12328
90049
(3019198) Lymphocytes [#/volume] in Blood
6083
46468
0.88
13.45
5.1
5.5
e9/l
1.7
1.9
3.02
5129
39795
(3013512) EKG study
4057
31853
0.86
13.44
4.9
4.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
538
5290
0.71
13.34
1.9
2.0
nmol/l
10.2
10.8
0.74
431
4393
(3019060) Gas panel - Arterial blood
1422
8128
1.25
13.34
3.7
4.3
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
104
318
2.31
13.34
1.1
1.1
mg/l
264.6
322.5
1.90
86
275
(3030981) Hyaline casts [#/volume] in Urine by Automated count
1086
6010
1.29
13.27
3.4
2.9
e6/l
0.4
0.3
1.11
1071
5902
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
187
2302
0.57
13.11
1.2
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
3739
23420
1.16
13.07
3.1
2.7
e6/l
5.5
5.0
1.73
3319
20424
(3048689) Calprotectin [Mass/mass] in Stool
919
8299
0.77
12.86
1.7
1.9
ug/g
193.3
169.8
0.77
662
6268
(3002030) Lymphocytes/100 leukocytes in Blood
5731
43849
0.88
12.76
5.5
5.9
%
23.4
25.3
25.46
5128
40037
(3007930) Methemoglobin/Hemoglobin.total in Blood
911
4958
1.31
12.61
4.0
4.7
%
0.9
0.9
2.84
872
4651
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
204
2426
0.59
12.56
1.9
2.9
u/ml
223.7
822.0
2.58
170
2203
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
149
1918
0.54
12.27
1.2
1.2
u/ml
11.7
5.7
0.35
24
332
(3020191) Ethanol [Moles/volume] in Serum or Plasma
128
445
2.03
12.03
1.3
1.2
promille
0.9
1.0
0.34
105
326
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1879
11179
1.21
11.99
4.9
3.8
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
986
5462
1.29
11.96
2.7
2.5
%
0.7
0.7
2.20
949
5244
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
149
1895
0.55
11.79
1.2
1.2
u/ml
16.4
5.1
0.33
15
218
(3047181) Lactate [Moles/volume] in Blood
655
3435
1.36
11.70
4.5
5.6
mmol/l
1.4
1.3
1.18
585
3042
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
55
131
2.96
11.53
2.3
2.3
nmol/l
146.3
130.5
0.65
46
112
(3004119) Hemoglobin [Mass/volume] in Venous blood
1261
7229
1.25
11.51
3.3
3.2
g/l
126.6
125.7
0.75
1242
7038
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
3489
21936
1.15
11.36
4.5
4.3
ng/l
227.5
429.5
3.31
3105
19364
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
117
403
2.05
11.31
1.1
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
93
1351
0.48
11.27
1.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
38
791
0.34
11.03
1.6
1.5
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
776
4210
1.31
11.02
3.1
3.8
mmol/l
1.5
1.4
0.62
759
4127
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
87
1279
0.48
10.93
1.2
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
488
2467
1.41
10.91
4.7
6.2
mmol/l
11.3
11.3
0.07
450
2198
(3018572) Chloride [Moles/volume] in Blood
488
2467
1.41
10.91
4.7
6.2
mmol/l
104.7
104.8
0.11
450
2198
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
125
1634
0.54
10.90
1.2
1.2
u/ml
1.1
5.2
2.06
14
137
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
168
2021
0.58
10.88
1.2
1.2
u/ml
36.5
41.2
0.07
12
120
(3041096) Erythrocytes [Presence] in Urine by Automated
3638
23012
1.15
10.78
5.1
4.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
337
3462
0.68
10.74
1.4
1.6
u/l
36.5
38.4
0.84
265
2875
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
107
1455
0.52
10.63
1.6
1.6
mg/l
3.4
3.5
0.03
79
1081
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
186
2165
0.60
10.58
2.6
2.1
%
212.3
210.1
0.12
170
2041
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
118
419
1.99
10.54
1.3
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
519
4931
0.73
10.44
1.8
1.9
g/l
1.5
1.4
0.23
434
4362
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
114
402
2.00
10.38
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
3562
22553
1.14
10.35
4.7
4.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1703
14039
0.84
10.11
2.6
3.7
u/l
248.1
250.8
0.28
1490
13137
(40760892) CBC W Ordered Manual Differential panel - Blood
2169
17525
0.85
10.10
4.1
4.6
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
554
2899
1.36
10.08
4.1
3.6
mmol/l
8.2
7.7
3.51
549
2834
(40768795) Lymph node Pathology biopsy report
57
950
0.42
10.06
1.1
1.2
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
576
3038
1.35
9.97
4.0
3.5
mmol/l
1.7
1.6
0.45
570
2968
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
918
5171
1.27
9.77
1.8
1.9
ug/l
2.9
2.3
0.48
707
4482
(42870588) Differential panel, method unspecified - Blood
4278
32927
0.89
9.75
4.7
5.4
—
—
—
0
0
(4198724)
33
63
3.70
9.71
2.2
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
207
2300
0.63
9.70
2.1
1.9
%
91.3
87.5
1.64
191
2169
(1761482) Bacteria [#/volume] in Urine by Culture
652
3521
1.32
9.61
6.0
4.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
87
1219
0.50
9.54
1.2
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
28
48
4.12
9.47
2.7
1.8
umol/l
23.0
17.4
1.22
28
48
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
90
301
2.11
9.47
1.4
1.6
umol/l
105.2
96.4
0.17
50
177
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
91
307
2.09
9.37
1.1
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
2786
17459
1.15
9.30
3.5
3.2
e6/l
3.1
2.6
1.64
1612
9865
(3051387) C reactive protein [Mass/volume] in Capillary blood
449
2307
1.38
9.19
4.2
3.9
mg/l
32.0
29.9
0.50
342
1530
(3009445) Proteinase 3 Ab [Units/volume] in Serum
475
4482
0.74
9.16
1.3
1.5
u/ml
30.7
19.3
—
7
101
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1930
15625
0.85
9.16
1.2
1.2
u/ml
1.7
1.7
0.00
438
3656
(1001926) Buprenorphine [Presence] in Urine by Screen method
83
273
2.15
9.12
1.9
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
4754
30864
1.12
8.99
2.4
2.5
u/l
57.2
60.2
2.69
4305
28226
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
433
4129
0.73
8.96
2.1
3.0
u/ml
166.8
2556.4
2.75
337
3513
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
201
2201
0.64
8.86
1.5
1.7
mg/l
13.0
12.5
0.31
173
1984
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
266
2749
0.68
8.82
1.6
1.5
—
—
—
0
0
(4281824)
64
968
0.46
8.81
1.2
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
20
27
5.22
8.81
1.6
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
70
219
2.26
8.69
1.5
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
76
1074
0.50
8.61
1.4
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
221
2344
0.66
8.39
2.2
1.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
355
3448
0.72
8.29
1.6
1.6
titre
166.0
255.9
0.64
20
163
(36304419) Bacteria [Presence] in Urine
4421
28692
1.12
8.28
3.9
3.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
281
2837
0.69
8.24
1.2
1.2
u/ml
0.5
1.0
1.53
30
280
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
130
1549
0.59
8.23
1.1
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
291
2919
0.70
8.23
1.6
1.4
iu/ml
19.0
16.3
—
7
71
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
88
1165
0.53
8.14
1.4
1.6
nmol/l
52.5
48.5
0.66
82
1096
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
819
4659
1.25
8.06
2.0
1.8
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
2705
17086
1.14
7.93
1.8
1.9
s
29.8
30.2
2.65
2598
16575
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1259
7499
1.20
7.90
1.7
2.1
nmol/l
404.1
383.7
1.71
1076
6781
(3045414) Leukocytes [Presence] in Urine
473
4365
0.76
7.85
2.3
2.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
402
3796
0.74
7.84
1.1
1.2
iu/ml
86.4
129.1
1.58
131
1249
(3003396) Base excess in Arterial blood by calculation
2184
13621
1.15
7.72
4.5
6.1
mmol/l
1.4
1.1
3.19
1645
10528
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
121
1441
0.59
7.68
1.5
1.4
pmol/l
381.1
250.6
0.40
115
1389
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
239
2451
0.68
7.67
2.5
2.1
g/l
3.6
3.7
0.36
222
2311
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
133
1546
0.60
7.66
3.4
3.9
iu/ml
413.9
2376.4
0.99
20
221
(3005719) IgG [Mass/volume] in Serum or Plasma
704
6144
0.80
7.45
2.6
2.7
g/l
10.7
10.7
0.10
603
5562
(3004616) Nuclear Ab [Presence] in Serum
79
1050
0.53
7.45
1.1
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
57
175
2.30
7.44
1.5
1.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
96
1205
0.56
7.44
1.2
1.3
nmol/l
0.2
0.3
0.04
11
94
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
753
6516
0.81
7.37
1.4
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
68
943
0.51
7.35
1.6
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
871
5042
1.23
7.33
2.1
1.9
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
96
1198
0.56
7.29
1.2
1.3
nmol/l
0.6
0.7
0.87
87
1139
(3011288) Drugs identified in Urine by Screen method
67
223
2.12
7.24
2.2
1.9
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
70
957
0.51
7.24
1.1
1.1
g/l
1.6
1.6
0.39
62
839
(3042111) Morphology [Interpretation] in Bone marrow Narrative
195
2054
0.66
7.22
1.3
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
43
692
0.44
7.09
1.2
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
911
5323
1.22
7.01
3.0
3.8
mmol/l
24.2
24.1
0.14
814
4748
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
113
1336
0.59
7.01
1.2
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
9202
67413
0.92
6.98
26.7
22.8
%
14.1
14.0
5.37
8913
65789
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
89
1111
0.56
6.80
1.2
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
4222
31985
0.91
6.63
2.4
2.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
176
1846
0.67
6.43
2.3
2.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
178
826
1.52
6.38
1.3
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
435
3943
0.77
6.38
1.3
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
148
1605
0.65
6.37
1.5
1.8
ug/l
18.5
23.7
1.72
142
1557
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
175
811
1.53
6.32
1.3
1.3
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
66
873
0.53
6.21
1.6
1.8
mg/l
4.5
4.8
0.21
57
819
(3027801) Oxygen [Partial pressure] in Arterial blood
2158
13642
1.13
6.17
4.5
6.1
kpa
11.2
11.8
6.07
2017
12882
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
2159
13652
1.13
6.15
4.6
6.1
kpa
5.0
5.1
3.05
2022
12898
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
454
2489
1.29
6.14
1.2
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
241
2366
0.71
6.12
1.9
1.4
g/l
1.1
1.2
0.18
224
2215
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
493
4377
0.79
6.12
2.5
2.7
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
213
1038
1.45
6.04
2.4
2.3
u/field
2.7
2.2
0.36
67
358
(3016879) Cocaine [Presence] in Urine
85
331
1.81
5.98
1.9
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
296
2802
0.74
5.97
1.8
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
144
1547
0.65
5.96
1.5
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
64
842
0.53
5.93
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
2080
13151
1.13
5.93
10.9
8.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
4586
30261
1.09
5.78
3.9
3.4
e6/l
0.6
0.5
0.85
3649
23221
(3014765) Yersinia sp identified in Stool by Organism specific culture
455
2521
1.28
5.70
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
456
2528
1.28
5.69
1.2
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
89
1055
0.59
5.67
1.1
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
46
146
2.22
5.66
2.1
2.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
46
146
2.22
5.66
2.1
2.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
185
1872
0.69
5.64
1.2
1.3
u/l
44.1
39.9
0.17
154
1609
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
105
1192
0.62
5.61
1.8
2.1
u/ml
985.1
2081.2
—
7
88
(3020891) Body temperature
794
4685
1.20
5.59
4.0
4.6
—
—
—
0
0
(3036603) Volume of Urine
47
668
0.49
5.59
2.1
1.5
ml
1704.2
1851.8
0.35
22
188
(3014111) Lactate [Moles/volume] in Serum or Plasma
1614
10081
1.14
5.56
4.2
5.7
mmol/l
1.5
1.4
5.95
1522
9635
(3016038) Potassium [Moles/volume] in Urine
169
801
1.49
5.55
1.1
1.1
mmol/l
34.3
35.3
0.22
134
662
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
321
2969
0.76
5.54
1.1
1.1
u/ml
1.8
1.0
—
10
45
(3003181) Sodium [Moles/volume] in Urine
410
2252
1.29
5.51
1.4
1.3
mmol/l
62.7
61.2
0.36
332
1818
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
239
2304
0.73
5.47
1.8
1.4
g/l
0.2
0.2
0.16
221
2153
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
87
352
1.75
5.43
1.9
2.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
87
352
1.75
5.43
1.9
2.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
24
434
0.39
5.38
1.1
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
1929
12218
1.13
5.33
4.7
6.3
%
94.8
95.2
1.89
1845
11708
(3017354) Segmented neutrophils/100 leukocytes in Blood
110
1220
0.63
5.33
2.8
3.4
%
61.2
59.8
0.20
59
747
(3027945) Reticulocytes/100 erythrocytes in Blood
2308
14776
1.12
5.30
2.1
2.3
%
1.8
1.8
0.37
1832
12869
(3023419) Bacteria identified in Sputum by Culture
142
1489
0.67
5.26
1.8
2.4
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
54
719
0.53
5.26
2.0
1.3
iu/ml
21.5
24.7
—
6
32
(3000764) Benzodiazepines [Presence] in Urine
86
351
1.73
5.23
2.0
1.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
128
1368
0.66
5.22
2.5
3.6
u/ml
32.4
44.0
0.93
118
1323
(3045424) Erythrocytes [Presence] in Urine
160
1633
0.69
5.15
1.6
1.5
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
62
786
0.55
5.13
1.0
1.1
%
113.2
115.9
0.28
51
676
(3024731) MCV [Entitic volume]
12827
92201
0.92
5.11
31.0
27.5
fl
91.9
91.9
0.27
12368
90343
(3000963) Hemoglobin [Mass/volume] in Blood
12829
92213
0.92
5.10
31.3
27.8
g/l
127.2
131.1
155.15
12356
90362
(3027008) Opiates [Presence] in Urine
86
354
1.72
5.09
2.0
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
12828
92202
0.92
5.08
31.1
27.6
e12/l
4.2
4.3
123.82
12177
88760
(3007461) Platelets [#/volume] in Blood
12826
92188
0.92
5.08
31.1
27.6
e9/l
237.3
237.7
0.27
12236
89183
(3009214) Lutropin [Units/volume] in Serum or Plasma
85
988
0.60
5.06
1.3
1.3
u/l
14.2
12.0
0.51
61
780
(3035941) MCH [Entitic mass]
12828
92197
0.92
5.06
30.9
27.5
pg
30.4
30.4
2.79
12363
90339
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1838
11647
1.13
5.05
3.4
3.1
ng/l
284.5
269.0
0.49
1680
10725
(3024980) IgG subclass 4 [Mass/volume] in Serum
101
1123
0.63
4.98
1.4
1.6
g/l
0.8
0.8
0.09
77
846
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
125
1328
0.66
4.98
1.2
1.2
u/ml
54.8
46.7
0.18
13
150
(3017143) Hepatitis C virus Ab [Presence] in Serum
740
6163
0.84
4.97
1.4
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
86
357
1.70
4.95
2.0
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
49
658
0.52
4.94
1.0
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
1101
6759
1.16
4.87
4.4
3.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
222
0.29
4.87
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
222
0.29
4.87
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
222
0.29
4.87
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
222
0.29
4.87
1.2
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
12837
92217
0.92
4.85
31.1
27.6
e9/l
7.3
7.0
22.33
12194
88808
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
11
15
5.17
4.81
7.8
9.3
—
—
—
0
0
(3010421) pH of Blood
533
3072
1.23
4.81
4.2
4.2
ph
7.4
7.4
1.28
440
2618
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
106
470
1.59
4.75
1.7
1.4
umol/l
15.2
14.9
0.15
101
433
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
38
543
0.49
4.67
1.2
1.1
u/ml
0.3
1.7
2.40
13
199
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
54
198
1.92
4.65
1.1
1.1
—
—
—
0
0
(4306422)
67
806
0.58
4.61
1.2
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
70
832
0.59
4.60
1.5
1.8
pmol/l
160.7
189.6
2.13
60
750
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
42
141
2.10
4.58
3.5
2.6
u/field
0.4
0.5
0.69
42
141
(3020779) Urea [Moles/volume] in Serum or Plasma
1344
10637
0.88
4.57
4.3
6.0
mmol/l
12.0
11.9
0.14
1202
9943
(3028271) Lactate [Moles/volume] in Capillary blood
342
1885
1.28
4.55
2.0
1.9
mmol/l
1.9
1.7
2.51
334
1838
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
57
215
1.87
4.53
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
366
3238
0.79
4.51
1.1
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
105
1131
0.65
4.51
1.1
1.3
mu/l
55.1
54.5
0.01
85
989
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
95
1039
0.64
4.40
1.2
1.3
nmol/l
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
205
1056
1.37
4.38
1.4
1.3
mosm/kgh2o
277.7
274.7
0.82
142
770
(3013707) Erythrocyte sedimentation rate by Westergren method
9305
67542
0.93
4.36
3.9
4.4
mm/h
16.6
15.4
8.46
8176
61269
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
56
213
1.86
4.35
1.1
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
279
1509
1.31
4.31
2.0
1.9
%
88.4
88.8
0.62
272
1489
(36660697) Celiac disease serology panel - Serum
685
5665
0.85
4.28
1.2
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
596
3518
1.20
4.27
3.6
3.2
nmol/l
0.8
0.8
0.01
449
2758
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
12510
86395
1.08
4.22
22.5
18.5
mg/l
31.2
27.7
21.72
10975
71790
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
71
821
0.61
4.21
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
152
1505
0.71
4.21
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
40
541
0.52
4.19
1.0
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1830
11718
1.11
4.19
1.8
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
257
2351
0.77
4.19
2.7
2.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
63
745
0.59
4.11
1.3
1.2
mmol/l
7.5
8.0
0.76
48
487
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
49
619
0.56
4.09
1.0
1.1
%
93.7
92.4
0.14
41
561
(3037556) Urate [Mass/volume] in Serum or Plasma
22
362
0.43
4.03
1.7
1.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
26
75
2.44
4.03
1.1
1.1
—
—
—
0
0
(4034850)
497
2905
1.21
3.97
12.5
13.0
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
57
225
1.79
3.97
1.6
1.2
nmol/l
96.5
137.8
1.66
42
165
(21494890) Protein electrophoresis panel - 24 hour Urine
138
1372
0.71
3.94
1.8
2.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
205
1914
0.75
3.91
1.1
1.1
titre
672.0
930.7
—
5
61
(3047189) Immunofixation for 24 hour Urine
49
610
0.56
3.90
1.3
1.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
92
984
0.66
3.89
1.1
1.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
100
1051
0.67
3.87
1.1
1.2
pmol/l
263.3
258.0
0.07
75
784
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
55
217
1.79
3.85
1.1
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
10
230
0.31
3.81
1.1
1.3
—
1.5
—
0
28
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
64
265
1.70
3.81
1.1
1.1
u/l
1.0
1.1
0.45
31
139
(3027944) Amphetamines [Presence] in Urine
79
346
1.61
3.81
2.1
1.4
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
20
52
2.71
3.79
1.1
1.2
%
51.1
46.5
0.16
15
29
(3036489) Thrombin time
363
3142
0.81
3.74
1.9
1.8
s
22.0
22.0
0.05
333
2841
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
54
214
1.78
3.74
1.1
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
9587
65725
1.06
3.74
29.2
25.4
g/l
329.8
330.6
13.83
9332
65033
(3004809) Band form neutrophils/100 leukocytes in Blood
213
1963
0.76
3.72
3.2
3.4
%
2.0
1.4
0.92
159
1483
(3012501) Base excess in Blood by calculation
460
2689
1.21
3.70
4.3
4.3
mmol/l
2.7
2.8
0.41
328
1839
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
339
2951
0.81
3.69
1.3
1.4
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
460
2691
1.21
3.68
4.3
4.3
kpa
5.1
5.0
0.75
440
2616
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
127
1262
0.71
3.65
1.2
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
214
1965
0.76
3.65
1.5
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
55
650
0.59
3.63
2.1
2.2
ug/min
464.2
109.1
0.39
13
158
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
143
0.25
3.62
1.0
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
33
450
0.52
3.61
1.0
1.0
u/ml
0.3
1.2
1.36
11
181
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
85
908
0.66
3.60
1.1
1.2
u/ml
2.8
5.4
0.98
25
292
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
57
666
0.60
3.59
1.0
1.1
u/ml
1.1
3.9
—
9
147
(3039162) Centromere protein B Ab [Units/volume] in Serum
82
882
0.65
3.59
1.3
1.2
u/ml
34.3
48.5
—
9
61
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1711
11009
1.11
3.59
4.9
6.7
g/l
119.8
119.0
0.86
1655
10595
(3023430) Cat dander IgE Ab [Units/volume] in Serum
15
274
0.39
3.57
1.0
1.0
u/ml
0.2
1.7
—
8
109
(3007566) Smooth muscle Ab [Titer] in Serum
206
1895
0.76
3.57
1.1
1.1
titre
81.1
156.6
2.01
19
127
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
107
1090
0.69
3.55
1.2
1.3
u/ml
112.5
124.9
0.68
30
246
(3003888) Timothy IgE Ab [Units/volume] in Serum
35
466
0.53
3.55
1.0
1.0
u/ml
1.1
3.1
1.21
12
202
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
4081
30293
0.93
3.52
4.3
5.1
%
21.5
22.6
5.15
2023
16902
(3014133) Dog dander IgE Ab [Units/volume] in Serum
17
292
0.41
3.51
1.0
1.0
u/ml
0.2
2.0
—
8
120
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
780
6280
0.87
3.49
5.6
7.4
mmol/l
24.4
24.3
0.17
690
5761
(3024471) HLA-A [Type]
5
139
0.25
3.48
1.0
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
736
5939
0.87
3.41
3.4
3.3
e9/l
4.4
4.3
0.43
451
4059
(3037692) Legionella sp identified in Specimen by Organism specific culture
24
356
0.47
3.40
1.5
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
83
879
0.66
3.39
1.1
1.2
u/ml
4.0
4.6
0.16
30
380
(3027315) Oxygen [Partial pressure] in Blood
459
2708
1.20
3.39
4.3
4.3
kpa
8.0
8.3
5.02
438
2633
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
2848
18798
1.08
3.38
3.2
3.0
e6/l
1.6
1.4
0.53
1662
11130
(3047007) Chlamydophila sp Ab [Presence] in Serum
67
740
0.64
3.35
1.3
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
464
2745
1.20
3.33
3.2
3.7
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
135
0.26
3.33
1.0
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
48
573
0.59
3.33
1.1
1.1
—
36.6
—
0
5
(3010726) Horse dander IgE Ab [Units/volume] in Serum
24
353
0.48
3.32
1.0
1.0
u/ml
0.2
1.3
—
6
85
(40758558) Short blood count panel - Blood
3125
23356
0.93
3.24
5.8
6.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
34
441
0.54
3.20
1.1
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
23
71
2.28
3.14
1.0
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
488
2917
1.18
3.14
1.2
1.2
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
14
247
0.40
3.12
1.0
1.0
—
5.4
—
0
30
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
257
2259
0.80
3.12
1.6
1.6
iu/ml
40.5
5.3
1.03
82
570
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
142
1347
0.74
3.11
1.5
1.5
%
71.0
63.3
1.93
94
835
(21494814) CD8 cells/100 lymphocytes in Specimen
22
324
0.48
3.09
2.8
1.7
—
—
—
0
0
(3012565) Volume of 24 hour Urine
41
498
0.58
3.07
1.8
2.2
ml
1696.1
1808.7
0.23
28
412
(3048929) Epstein Barr virus Ab [Presence] in Serum
141
1335
0.74
3.06
1.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
731
4519
1.15
3.06
1.3
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
18
284
0.45
3.05
1.1
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
9387
64515
1.06
3.05
3.8
4.0
pmol/l
15.3
15.2
0.98
8101
56688
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
23
332
0.49
3.05
1.7
1.7
e6/l
1575.8
16007.8
1.75
13
190
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
57
0.00
3.04
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
121
612
1.40
3.01
1.8
1.9
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
22
320
0.48
2.99
1.8
1.5
ug/l
10.7
9.9
0.11
22
285
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
200
1800
0.78
2.99
2.7
3.1
—
—
—
0
0
(44813793)
32
410
0.55
2.92
1.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
72
331
1.53
2.92
1.1
1.1
—
—
—
0
0
(4268621)
50
569
0.62
2.90
2.1
2.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
825
6531
0.88
2.90
2.5
2.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
37
454
0.57
2.90
2.0
2.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
22
316
0.49
2.89
1.1
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
27
93
2.05
2.87
1.1
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
137
0.31
2.87
1.2
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
83
847
0.69
2.86
1.7
1.9
ug/l
2.8
4.1
1.43
71
732
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
109
1061
0.72
2.86
1.1
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
7
149
0.33
2.85
3.6
2.5
u/l
123.9
1417.9
—
7
141
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
5185
37984
0.94
2.84
4.5
5.8
ug/l
6.3
4.7
0.62
4326
33311
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
43
504
0.60
2.83
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
43
503
0.60
2.81
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
43
503
0.60
2.81
1.2
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
28
367
0.54
2.78
1.9
1.8
e6/l
433.2
4736.9
1.03
18
249
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
183
1646
0.78
2.75
1.6
1.5
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
43
500
0.60
2.75
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
43
500
0.60
2.75
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
43
499
0.61
2.73
1.2
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
61
654
0.66
2.73
1.1
1.2
titre
104.5
121.4
0.24
11
118
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
20
290
0.49
2.72
2.9
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
97
953
0.72
2.71
1.2
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
54
237
1.61
2.69
1.5
1.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
278
2380
0.82
2.68
2.2
2.6
mg/l
1.8
1.8
0.12
227
2089
(3025130) Human papilloma virus identified in Specimen
36
433
0.58
2.65
1.8
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
50
554
0.63
2.62
1.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
69
715
0.68
2.62
2.9
3.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
162
1468
0.78
2.61
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
131
0.32
2.59
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
131
0.32
2.59
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
131
0.32
2.59
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
131
0.32
2.59
1.3
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
103
522
1.39
2.59
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
78
788
0.70
2.58
1.1
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2653
19785
0.93
2.57
1.6
1.7
mg/l
1.7
1.6
0.73
2038
15572
(3033658) Prothrombin time (PT) actual/Normal
3310
24503
0.94
2.55
3.7
4.0
%
80.0
82.4
6.11
3190
23957
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
46
197
1.65
2.54
1.1
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
169
1517
0.78
2.53
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
72
735
0.69
2.53
1.2
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
45
504
0.63
2.49
1.0
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
350
2911
0.84
2.49
1.1
1.1
titre
304.2
217.9
0.27
13
51
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1446
9403
1.09
2.49
3.5
3.9
mmol/l
1.2
1.2
0.17
1173
8132
(4015189)
27
344
0.55
2.47
1.9
2.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
138
0.36
2.46
1.3
1.5
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
49
0.00
2.46
0.0
3.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
18
259
0.49
2.43
1.3
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
272
1584
1.21
2.42
1.7
1.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
63
295
1.51
2.41
1.6
1.7
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
14
39
2.53
2.40
1.6
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
69
701
0.69
2.39
1.1
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
9
157
0.40
2.36
10.9
12.8
mmol/l
5.4
5.4
—
9
157
(3009871) Measles virus Ab [Titer] in Serum
5
111
0.32
2.34
1.6
1.7
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
32
127
1.78
2.32
1.2
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1438
9382
1.09
2.31
1.7
2.0
g/l
0.2
0.2
0.22
1228
8626
(4146454)
146
1316
0.78
2.30
2.4
2.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
23
299
0.54
2.28
2.0
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
382
3126
0.86
2.26
1.7
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1106
7142
1.10
2.25
3.2
3.7
mmol/l
2.1
2.0
0.31
783
5301
(3000093) Morphology [Interpretation] in Blood Narrative
129
1176
0.77
2.23
1.1
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
66
666
0.70
2.23
1.5
1.4
iu/l
44.3
33.2
1.45
55
570
(3003327) Ova and parasites identified in Stool by Light microscopy
259
2186
0.83
2.22
1.6
1.6
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
7
130
0.38
2.21
2.6
1.5
pmol/l
60.7
58.5
—
7
99
(3015235) Bicarbonate [Moles/volume] in Capillary blood
520
3222
1.14
2.20
2.7
3.1
mmol/l
25.1
25.0
0.14
469
2809
(4024509)
129
1173
0.77
2.20
1.6
1.7
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
11
181
0.43
2.17
1.1
1.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
21
74
2.00
2.16
1.0
1.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
105
979
0.75
2.16
1.0
1.2
u/ml
287.7
285.4
0.03
63
579
(3025577) Chromium [Mass/volume] in Blood
85
817
0.73
2.15
1.8
2.0
ug/l
1.8
2.2
0.80
65
682
(3011412) CD3 cells [#/volume] in Blood
73
718
0.72
2.14
2.5
1.8
e9/l
1.0
1.1
0.33
49
447
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
9
149
0.43
2.12
1.1
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
32
131
1.72
2.12
1.2
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
65
2.06
2.12
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
29
345
0.59
2.11
1.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
14
42
2.35
2.09
1.3
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
12169
86884
0.95
2.08
21.5
18.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
6784
46535
1.05
2.07
11.8
11.7
inr
1.4
1.4
1.73
1718
12503
(3023103) Potassium [Moles/volume] in Serum or Plasma
12770
91061
0.95
2.06
26.6
22.7
mmol/l
4.0
4.0
1.29
12250
88510
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
18
61
2.08
2.06
1.1
1.1
mmol/l
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
30
350
0.60
2.04
1.2
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
951
7310
0.91
2.02
5.5
7.5
%
92.6
93.7
4.47
941
7281
(3042936) Bacteria identified in Isolate by Culture
1970
14714
0.94
2.01
2.0
2.0
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
73
709
0.72
2.00
1.2
1.4
g/l
7.3
7.1
0.08
48
496
(3024139) IgG subclass 3 [Mass/volume] in Serum
73
709
0.72
2.00
1.2
1.4
g/l
0.4
0.5
0.07
49
503
(3028192) IgG subclass 2 [Mass/volume] in Serum
73
709
0.72
2.00
1.2
1.4
g/l
2.7
2.9
0.30
49
502
(3009343) pH of Capillary blood
1137
7397
1.09
1.99
3.2
3.8
ph
7.4
7.4
0.42
142
980
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
25
97
1.82
1.98
1.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
38
416
0.64
1.97
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
16
221
0.51
1.97
1.1
1.0
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
49
509
0.68
1.97
1.3
1.4
%
4.2
3.6
0.12
13
114
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
59
592
0.70
1.97
4.3
4.9
u/ml
87.4
118.9
0.18
11
167
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
15
48
2.20
1.96
1.0
1.0
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
419
3366
0.87
1.96
1.9
2.3
g/l
0.0
0.0
0.00
348
3053
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
169
1466
0.81
1.96
1.2
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
12762
90967
0.95
1.95
26.6
22.6
mmol/l
139.6
139.5
6.11
12270
88545
(40767503) Oxygen content in Capillary blood by calculation
421
2597
1.15
1.95
2.5
2.6
%
16.1
15.7
0.98
191
1410
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
37
0.00
1.94
0.0
2.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
122
1095
0.78
1.92
1.1
1.2
u/l
62.4
60.6
0.10
75
724
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
61
300
1.43
1.90
1.1
1.1
ng/l
78.0
607.2
—
9
79
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
38
169
1.59
1.88
2.6
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
452
2809
1.14
1.88
2.1
2.3
g/l
126.2
125.9
0.09
363
2052
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
43
453
0.67
1.87
5.5
6.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
319
2602
0.86
1.87
1.6
1.6
e6/l
22014.0
14425.8
1.16
233
1838
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
609
4763
0.90
1.85
1.9
2.2
g/l
10.2
10.3
0.37
448
3884
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
12
178
0.47
1.84
1.2
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
189
1608
0.83
1.83
1.3
1.2
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
7
120
0.41
1.83
1.0
1.1
—
0.6
—
0
44
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
599
4684
0.90
1.82
2.0
2.3
g/l
3.2
3.1
0.23
399
3554
(4062490)
75
713
0.74
1.82
1.3
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
403
3226
0.88
1.82
1.6
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
196
1660
0.83
1.81
1.3
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
566
4438
0.90
1.81
2.3
3.1
mg/l
45.9
52.0
0.45
440
3604
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
111
999
0.78
1.81
1.1
1.1
iu/ml
83.9
481.4
0.76
16
175
(3048879) Bone marrow aspiration report
39
415
0.66
1.80
1.2
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
122
1085
0.79
1.80
1.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
111
0.38
1.80
1.3
1.5
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
5
8
4.40
1.79
1.0
1.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
568
4447
0.90
1.78
2.3
3.1
mg/l
60.4
84.0
0.89
438
3612
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
147
1278
0.81
1.77
3.0
3.5
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
56
555
0.71
1.77
1.1
1.1
u/l
40.2
31.1
0.39
37
404
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
56
555
0.71
1.77
1.1
1.1
u/l
92.5
92.5
0.00
42
416
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
187
1585
0.83
1.75
1.2
1.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
8
20
2.82
1.75
1.0
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1144
7491
1.08
1.75
3.3
3.8
kpa
5.2
5.2
1.70
999
6858
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
100
906
0.78
1.73
1.2
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
100
906
0.78
1.73
1.2
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
100
906
0.78
1.73
1.2
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
87
463
1.33
1.73
1.1
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
19
71
1.89
1.71
1.1
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
18
228
0.56
1.71
3.3
2.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
109
975
0.79
1.71
1.6
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
39
180
1.53
1.68
1.1
1.1
miu/ml
1636.1
1711.1
0.12
39
180
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
106
0.40
1.68
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
106
0.40
1.68
1.3
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
116
1027
0.79
1.67
1.4
1.5
%
18.2
27.0
3.25
79
639
(3015076) Soybean IgE Ab [Units/volume] in Serum
5
94
0.37
1.66
1.0
1.0
—
0.4
—
0
12
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
433
3425
0.89
1.64
1.8
2.3
g/l
0.0
0.0
0.22
348
3066
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
34
363
0.66
1.62
2.4
2.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
109
605
1.27
1.61
2.5
2.0
u/field
1.9
2.4
0.42
70
403
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
41
420
0.69
1.59
1.3
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
181
1522
0.84
1.59
1.2
1.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
7
112
0.44
1.59
1.3
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
656
5063
0.91
1.58
1.9
2.2
g/l
3.9
3.8
0.40
396
3490
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
52
259
1.42
1.57
1.3
1.5
pmol/l
16.6
17.1
0.21
38
204
(3050129) First trimester maternal screen panel - Serum or Plasma
10
148
0.48
1.56
1.6
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
13
176
0.52
1.56
5.8
8.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
547
4255
0.90
1.55
1.9
2.4
g/l
1.1
1.2
0.01
410
3528
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
6
104
0.41
1.54
1.0
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
659
5073
0.91
1.52
2.0
2.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
6
14
3.02
1.52
1.0
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
660
5077
0.91
1.50
2.0
2.2
g/l
7.6
7.5
0.59
404
3635
(3006462) Nitrate [Presence] in Urine
54
521
0.73
1.50
5.0
4.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
180
1065
1.19
1.49
1.8
1.6
u/ml
27.6
26.1
0.18
48
215
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
223
1830
0.86
1.48
1.3
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
952
7206
0.93
1.48
1.4
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
110
963
0.80
1.47
1.3
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
557
4314
0.91
1.47
2.3
3.1
ratio
2.1
3.6
1.25
44
312
(3019977) pH of Arterial blood
127
727
1.23
1.47
2.2
2.4
ph
7.4
7.4
0.24
30
289
(21494815) CD4 cells/100 lymphocytes in Specimen
61
575
0.75
1.46
2.2
1.8
%
50.1
37.7
—
7
59
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
13
45
2.04
1.45
1.3
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
22
251
0.62
1.45
3.5
2.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
187
1115
1.18
1.43
1.6
1.6
—
—
—
0
0
(4211845)
60
564
0.75
1.42
4.8
4.0
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
29
309
0.66
1.41
1.6
1.4
nmol/l
0.1
0.2
0.85
19
225
(3008757) Leukocyte morphology finding [Identifier] in Blood
152
1281
0.83
1.41
4.1
3.8
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
18
214
0.59
1.40
5.9
8.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
190
1137
1.18
1.40
2.7
2.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
2001
14753
0.95
1.37
3.9
5.1
mmol/l
1.0
1.0
0.39
1721
13441
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
30
315
0.67
1.37
1.0
1.1
iu/ml
14.1
12.6
—
7
71
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
471
3660
0.90
1.35
1.8
2.3
g/l
0.0
0.0
0.03
383
3287
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
7
108
0.46
1.34
1.6
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
174
1440
0.85
1.32
1.4
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
362
2279
1.12
1.32
2.4
2.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
2152
14523
1.05
1.32
4.7
6.1
mmol/l
104.5
104.2
1.73
2066
14184
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
18
210
0.60
1.32
1.3
1.4
ng/l
121.3
132.2
0.19
18
210
(40768446) Kidney Pathology biopsy report
21
236
0.63
1.32
1.0
1.5
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
17
201
0.60
1.31
2.8
2.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
67
612
0.77
1.31
1.3
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
67
612
0.77
1.31
1.3
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
601
4608
0.92
1.31
2.6
2.6
u/ml
0.4
0.3
0.19
343
2620
(40768806) Pleura Pathology biopsy report
200
1635
0.86
1.31
1.5
1.6
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
270
2159
0.88
1.29
1.3
1.5
g/l
29.8
31.3
1.20
243
1909
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
52
490
0.75
1.28
2.3
1.9
e6/l
528.0
577.3
0.21
15
216
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
508
3919
0.91
1.27
1.8
2.2
g/l
36.0
36.8
1.97
369
3238
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
59
545
0.76
1.27
1.5
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
708
5381
0.92
1.26
2.6
2.9
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
63
338
1.31
1.26
1.1
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
30
309
0.68
1.26
1.1
1.1
ratio
1.1
1.1
—
9
91
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
77
686
0.79
1.25
1.1
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2189
16060
0.95
1.24
2.3
2.6
%
20.0
21.0
2.22
1625
13482
(3027035) Albumin [Mass/time] in 24 hour Urine
7
104
0.47
1.23
1.6
1.3
—
804.0
—
0
12
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
72
644
0.79
1.21
1.6
1.5
u/l
4.5
6.8
0.86
34
294
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
58
533
0.77
1.21
2.2
1.7
%
15.9
15.9
0.01
32
192
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
77
682
0.79
1.20
1.2
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
38
371
0.72
1.19
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
38
371
0.72
1.19
1.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
107
914
0.82
1.19
1.1
1.1
u/ml
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
202
1635
0.87
1.18
1.4
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
116
981
0.83
1.17
1.2
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
17
193
0.62
1.14
1.1
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
44
416
0.74
1.14
1.2
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
44
416
0.74
1.14
1.2
1.7
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
29
293
0.70
1.12
2.2
1.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
17
192
0.62
1.12
2.1
1.6
ug/l
9.6
10.0
0.18
17
192
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
12
45
1.88
1.12
1.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
58
526
0.78
1.12
2.3
1.8
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
23
105
1.54
1.11
1.1
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
233
1447
1.14
1.11
5.4
5.8
mg/l
13.0
12.5
0.87
200
1295
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
98
837
0.82
1.11
1.0
1.1
—
14.5
—
0
21
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1326
8884
1.06
1.11
2.9
3.6
ng/l
93.6
99.6
1.41
1016
7368
(3020393) Adenovirus Ag [Presence] in Stool
21
94
1.57
1.10
1.0
1.0
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
70
619
0.80
1.10
1.2
1.2
u/l
115.6
92.6
0.60
60
540
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
13
156
0.59
1.10
1.8
4.1
u/l
35.8
43.2
—
8
52
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
78
681
0.81
1.09
1.2
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
26
266
0.69
1.09
1.1
1.2
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
61
547
0.78
1.08
2.1
1.8
%
72.3
70.1
0.42
54
515
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
14
164
0.60
1.08
1.3
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
215
1719
0.88
1.08
1.3
1.5
e6/l
56607.3
62741.1
0.13
139
1002
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
6
88
0.48
1.07
1.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
38
194
1.38
1.07
1.0
1.1
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
16
67
1.68
1.07
1.8
1.5
mmol/l
1.2
1.1
—
9
38
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
11
137
0.57
1.07
6.5
7.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
40
379
0.74
1.07
1.1
1.4
umol/l
24.3
12.0
0.41
29
258
(3021901) Oxygen saturation in Capillary blood
384
2462
1.10
1.06
2.4
2.9
—
—
—
0
0
(3019225) pH of Specimen
1564
11513
0.95
1.05
4.6
4.5
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
33
321
0.72
1.04
1.2
1.3
u/l
46.5
33.8
0.83
19
259
(3029075) Extractable nuclear Ab panel - Serum
19
205
0.65
1.04
1.1
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
112
661
1.20
1.04
3.3
3.7
—
—
—
0
0
(4133840)
13
153
0.60
1.03
1.6
1.2
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
21
221
0.67
1.03
1.0
1.1
umol/24h
0.6
0.7
—
10
94
(3001893) Eosinophils/100 leukocytes in Pleural fluid
58
518
0.79
1.01
1.4
1.4
%
2.4
2.6
0.05
42
431
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
48
439
0.77
1.01
1.8
1.5
u/l
5.2
6.2
1.06
39
353
(3018133) Calcium [Moles/volume] in Urine
7
95
0.52
1.01
1.1
1.7
mmol/l
2.3
2.7
—
7
77
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
42
391
0.76
1.01
5.0
5.4
%
57.0
72.2
2.03
33
303
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
180
1448
0.87
1.01
1.2
1.4
u/l
369.0
456.6
0.59
165
1366
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
21
0.00
1.00
0.0
1.1
—
8.2
—
0
21
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
22
0.00
1.00
0.0
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
11
42
1.85
0.99
1.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
34
325
0.74
0.98
1.7
1.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
10
124
0.57
0.97
1.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
16
176
0.64
0.97
1.1
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
276
2157
0.90
0.97
1.5
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
46
420
0.77
0.97
1.3
1.7
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
7
25
1.97
0.96
1.9
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
238
1874
0.89
0.96
1.3
1.5
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
25
121
1.46
0.96
3.0
6.0
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
13
149
0.61
0.94
1.0
1.2
—
10.6
—
0
8
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
13
148
0.62
0.92
1.0
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
62
542
0.81
0.92
1.1
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
62
542
0.81
0.92
1.1
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
62
542
0.81
0.92
1.1
1.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
15
165
0.64
0.92
1.3
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2339
17014
0.96
0.92
2.2
2.5
g/l
2.2
2.2
7.00
2016
15533
(3020650) Glucose [Presence] in Urine
18
190
0.67
0.91
2.9
1.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
73
0.48
0.91
1.0
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
572
4315
0.93
0.91
1.2
1.3
au/ml
46.5
55.7
0.37
22
184
(3006922) Hepatitis E virus Ab [Presence] in Serum
44
400
0.77
0.91
1.0
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
75
0.47
0.91
2.2
4.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
24
239
0.71
0.90
1.1
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
9
111
0.57
0.90
1.0
3.3
—
—
—
0
0
(3016750) Collection duration of Urine
79
671
0.83
0.89
2.0
2.0
min
509.2
499.9
0.31
55
468
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2370
17219
0.96
0.88
2.3
2.7
mmol/l
0.8
0.8
0.04
2047
15798
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
49
437
0.79
0.88
1.2
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
8
30
1.88
0.88
1.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
47
421
0.79
0.87
1.1
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
25
124
1.42
0.86
1.3
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
6
21
2.01
0.86
1.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
33
309
0.75
0.86
1.3
1.3
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
128
1039
0.87
0.85
1.6
1.9
g/24h
1.2
0.7
—
9
30
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
20
95
1.48
0.85
1.1
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
143
880
1.15
0.84
1.3
1.3
titre
241.5
391.5
0.58
26
82
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
32
300
0.75
0.84
7.3
3.1
u/ml
49.7
60.2
—
7
30
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
70
597
0.83
0.84
1.2
1.2
u/l
40.5
28.0
0.70
56
510
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
42
379
0.78
0.84
1.9
1.9
u/ml
1090.9
1736.7
1.37
42
367
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
25
243
0.72
0.83
1.2
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
169
1343
0.89
0.83
1.3
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
437
2858
1.08
0.83
2.5
2.9
kpa
7.5
7.8
2.75
411
2632
(3025549) Creatine [Moles/time] in 24 hour Urine
19
90
1.49
0.82
1.2
1.4
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
18
185
0.69
0.82
1.1
1.2
%
109.0
114.1
0.31
12
160
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
49
432
0.80
0.81
1.2
1.2
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
18
0.00
0.81
0.0
8.9
—
39.8
—
0
18
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
17
79
1.52
0.80
1.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
17
79
1.52
0.80
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
17
79
1.52
0.80
1.0
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
19
0.00
0.80
0.0
1.5
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
19
0.00
0.80
0.0
1.8
—
2.1
—
0
11
(3043410) Blood group antigens tested for on Red Blood Cells
35
321
0.77
0.80
1.7
1.8
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
68
395
1.21
0.80
4.1
3.5
%
53.8
54.9
0.16
68
374
(3000330) Specific gravity of Urine by Test strip
900
6035
1.05
0.79
5.3
4.0
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
122
987
0.87
0.79
2.5
3.1
mg/l
60.9
37.0
0.59
87
737
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
6
23
1.84
0.78
1.5
1.4
nmol/l
503.6
397.3
—
6
23
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
49
275
1.26
0.78
1.3
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
172
1359
0.89
0.78
1.3
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
47
414
0.80
0.78
1.1
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
15
158
0.67
0.78
1.1
1.2
—
112.0
—
0
5
(3025018) Bordetella pertussis Ab [Titer] in Serum
29
271
0.75
0.76
1.2
1.3
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
138
855
1.14
0.76
1.3
1.3
titre
28.6
65.1
—
7
82
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
847
6267
0.95
0.76
1.5
1.6
g/l
1.6
1.6
0.79
655
5340
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
211
1644
0.90
0.75
1.2
1.4
—
—
—
0
0
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
12
52
1.63
0.75
2.0
1.2
u/field
1.1
1.0
—
7
28
(3002619) Bacteria identified in Specimen by Culture
23
221
0.73
0.73
1.4
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
1452
10602
0.96
0.73
2.0
2.5
g/l
65.0
65.9
3.53
1191
9396
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
9
39
1.63
0.73
1.0
1.1
—
35.7
—
0
11
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
66
387
1.20
0.72
1.9
1.6
u/l
2543.6
1130.6
0.29
18
149
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
64
540
0.83
0.72
1.1
1.6
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
74
439
1.19
0.72
1.3
1.3
nmol/l
1.2
1.2
0.03
52
332
(3036782) Glucose [Moles/volume] in Pleural fluid
175
1372
0.90
0.71
1.2
1.4
mmol/l
6.1
6.4
0.71
157
1275
(3005988) Vibrio sp identified in Specimen by Organism specific culture
171
1342
0.90
0.71
1.3
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
88
721
0.86
0.70
1.4
1.6
%
9.6
10.6
1.34
88
721
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
177
1385
0.90
0.70
1.3
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
41
361
0.80
0.70
1.7
1.8
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
52
446
0.82
0.70
1.0
1.0
mg/l
290.2
292.6
0.08
39
394
(3000060) B lymphocytes [#/volume] in Blood
24
124
1.36
0.69
2.3
1.8
e6/l
2424.0
1217.3
0.20
15
62
(3025468) Yersinia sp identified in Specimen by Organism specific culture
171
1339
0.90
0.69
1.3
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
216
1671
0.91
0.69
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
171
1338
0.90
0.68
1.3
1.3
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
5
66
0.53
0.68
1.0
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
46
398
0.81
0.68
1.2
1.2
g/l
38.4
40.2
0.54
27
192
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
66
551
0.84
0.67
1.2
1.2
mmol/l
11.0
12.1
0.43
21
164
(3001122) Ferritin [Mass/volume] in Serum or Plasma
5401
37483
1.02
0.67
2.8
2.9
ug/l
147.1
158.5
2.48
4620
33532
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
11
119
0.65
0.67
1.0
1.1
iu/ml
3.6
16.8
—
5
45
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
92
0.61
0.65
1.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
25
132
1.33
0.64
1.3
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
49
418
0.83
0.64
1.1
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
74
0.57
0.63
1.3
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
75
0.56
0.63
1.2
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
139
1093
0.90
0.63
1.1
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
372
2799
0.93
0.62
2.0
2.3
ug/min
115.3
102.6
0.18
184
1579
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
24
222
0.76
0.62
1.2
1.1
pmol/l
255.1
273.5
0.12
15
149
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
14
0.00
0.62
0.0
1.1
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
14
0.00
0.62
0.0
3.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
295
2236
0.93
0.61
1.4
1.3
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
16
0.00
0.61
0.0
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
16
0.00
0.61
0.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
129
1015
0.89
0.60
1.1
1.1
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
27
244
0.78
0.59
1.6
1.6
ug/l
120.5
113.3
0.11
22
203
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
52
437
0.84
0.59
2.4
1.9
e9/l
0.2
0.2
0.92
47
394
(3025315) Body weight
7
82
0.60
0.59
6.9
5.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
444
3313
0.94
0.59
2.4
3.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
246
1873
0.92
0.58
1.3
1.5
e6/l
3177.4
2293.7
0.43
185
1342
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
231
1763
0.92
0.58
1.6
1.6
iu/l
3.0
4.5
2.77
64
493
(3035320) C reactive protein [Mass/volume] in Body fluid
88
707
0.88
0.57
3.5
2.7
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
94
582
1.14
0.57
1.2
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
94
582
1.14
0.57
1.2
1.4
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
148
1151
0.91
0.56
1.2
1.3
u/l
20.6
12.4
1.22
128
1054
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
73
593
0.87
0.56
1.3
1.4
%
60.1
67.6
0.79
46
485
(3014148) Varicella zoster virus Ab [Titer] in Serum
73
446
1.15
0.54
1.1
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
70
0.60
0.53
1.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
104
0.68
0.53
1.6
1.5
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
6
71
0.60
0.53
6.3
4.4
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
37
213
1.22
0.53
1.9
1.8
%
9.2
10.6
0.16
30
189
(3050794) Legionella sp Ab [Presence] in Serum
6
72
0.59
0.52
1.2
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
6
72
0.59
0.52
1.0
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
26
231
0.79
0.52
1.9
2.0
ug/l
3.2
3.6
0.34
13
92
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
56
458
0.86
0.49
2.3
1.9
e6/l
400.5
505.1
1.10
47
394
(3037756) Immunofixation for Serum or Plasma
391
2907
0.95
0.49
1.3
1.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
1010
7351
0.97
0.49
5.2
7.3
%
1.5
1.3
5.41
995
7293
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
120
933
0.91
0.48
1.2
1.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
33
1.49
0.48
1.1
1.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
134
1035
0.91
0.47
1.2
1.4
e6/l
142600.2
189071.1
0.28
86
710
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
59
0.60
0.46
1.2
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
59
0.60
0.46
1.2
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
69
552
0.88
0.46
1.8
2.1
mmol/l
8.7
9.0
0.33
54
420
(3001964) Herpes simplex virus Ag [Presence] in Specimen
28
242
0.81
0.46
1.5
1.3
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
14
72
1.37
0.45
1.1
1.2
g/l
0.1
0.1
—
9
53
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
10
100
0.70
0.44
1.3
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
128
986
0.91
0.44
1.2
1.5
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
1009
7324
0.97
0.43
5.2
7.4
%
0.7
0.7
4.82
993
7265
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
29
248
0.82
0.43
1.2
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
107
684
1.10
0.42
1.1
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
12
115
0.73
0.42
1.6
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
11225
78674
1.02
0.42
5.0
5.0
mu/l
2.0
2.1
2.41
9854
69587
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
58
357
1.15
0.42
1.2
1.4
%
16.9
20.9
0.60
38
300
(37021550) Renin [Units/volume] in Plasma --upright
23
201
0.81
0.42
1.3
1.3
mu/l
43.7
70.7
0.91
15
140
(3003129) Base excess in Capillary blood by calculation
37
308
0.85
0.42
1.5
1.9
mmol/l
1.4
0.7
0.54
31
288
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
11
0.00
0.42
0.0
6.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
11
0.00
0.42
0.0
3.0
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
11
0.00
0.42
0.0
3.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
102
792
0.91
0.42
1.2
1.4
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
12
0.00
0.42
0.0
1.1
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
12
0.00
0.42
0.0
1.0
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
12
0.00
0.42
0.0
1.0
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
62
384
1.14
0.42
4.2
6.5
mmol/l
24.6
24.8
0.09
56
345
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
7409
51776
1.01
0.41
4.2
5.9
umol/l
12.6
12.4
0.49
6769
49013
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
13
67
1.37
0.41
1.2
1.1
u/field
0.9
1.1
—
7
43
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
81
636
0.90
0.41
1.6
1.7
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
27
231
0.82
0.41
1.4
1.3
g/l
22.9
53.6
0.68
19
187
(3034092) Cytoplasmic Ig cells/100 cells in Blood
17
92
1.30
0.41
12.4
13.0
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
13
0.00
0.41
0.0
1.2
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
13
0.00
0.41
0.0
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
42
253
1.17
0.41
1.1
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
86
546
1.11
0.40
1.9
2.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
323
2392
0.95
0.38
1.3
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
847
6148
0.97
0.38
6.0
8.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
9
47
1.35
0.38
1.3
1.6
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
35
209
1.18
0.38
1.3
1.3
%
21.8
21.7
0.01
22
161
(40763480) Human metapneumovirus Ag [Presence] in Specimen
10
50
1.41
0.37
1.0
1.2
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
56
348
1.13
0.37
1.2
1.4
%
75.8
61.5
3.90
42
300
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
6906
49043
0.99
0.37
3.2
3.1
u/l
55.5
56.7
0.37
6013
43923
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
96
0.73
0.37
1.4
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
33
273
0.85
0.36
2.2
2.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
70
549
0.90
0.36
1.0
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
127
967
0.92
0.36
2.0
2.2
ml
674.6
646.9
0.27
72
615
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
6
29
1.46
0.36
1.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
5
57
0.62
0.36
1.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
22
188
0.82
0.35
1.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
18
101
1.26
0.35
1.0
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
648
4423
1.03
0.34
3.8
4.2
mmol/l
25.1
24.9
0.63
535
4015
(3011335) Digoxin [Mass/volume] in Serum or Plasma
18
157
0.81
0.34
3.2
2.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
38
308
0.87
0.34
1.2
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
6
62
0.68
0.33
1.2
1.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
6
63
0.67
0.33
2.8
3.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
12
110
0.77
0.33
1.7
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
1178
8115
1.02
0.33
5.6
4.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
25
147
1.20
0.33
1.1
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
10
94
0.75
0.33
1.0
1.1
umol/24h
1.8
1.7
—
10
94
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
664
4821
0.97
0.33
2.2
2.4
au/ml
64.8
28.1
—
7
127
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
98
749
0.92
0.32
1.1
1.2
nmol/l
1.1
1.5
3.85
89
676
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
22
128
1.21
0.32
1.2
1.1
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
17
147
0.81
0.31
1.0
1.2
u/l
14.4
17.2
—
10
101
(3017569) Oxygen content in Arterial blood
82
630
0.92
0.31
2.3
2.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
239
1768
0.95
0.30
2.9
3.1
e9/l
4.9
4.4
1.19
239
1762
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
216
1601
0.95
0.30
2.0
2.2
mg/l
32.6
28.1
0.40
56
382
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
149
987
1.06
0.29
1.3
1.5
—
—
—
0
0
(3001729) Color of Synovial fluid
19
110
1.22
0.29
1.5
1.7
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
8
43
1.31
0.28
1.0
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
34
209
1.15
0.28
1.1
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
22
183
0.85
0.28
1.2
1.2
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
59
457
0.91
0.27
1.3
1.3
ug/l
778.9
210.6
0.57
36
252
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
25
205
0.86
0.27
1.1
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
87
661
0.93
0.27
1.3
1.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
18
105
1.21
0.26
1.1
1.1
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
14
121
0.82
0.26
1.1
1.2
mmol/l
6.1
6.1
—
5
55
(40757494) Bilirubin.total [Moles/volume] in Blood
81
616
0.93
0.26
2.0
2.1
umol/l
18.4
24.7
—
10
56
(3004588) Protein electrophoresis panel - Serum or Plasma
1238
8877
0.98
0.25
2.0
2.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
11
97
0.80
0.24
1.4
1.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
102
674
1.07
0.24
1.5
1.5
—
2.4
—
0
10
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
15
127
0.83
0.23
1.8
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3708
26344
0.99
0.22
2.8
3.1
u/l
34.8
37.3
0.96
3393
24637
(3023511) Choriogonadotropin [Units/volume] in Urine
21
127
1.17
0.22
1.5
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
10237
72375
0.99
0.22
24.5
20.5
%
36.2
37.7
23.06
5229
42077
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
8
0.00
0.22
0.0
6.7
—
8.9
—
0
8
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.22
0.0
1.0
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.22
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
8
0.00
0.22
0.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
37
289
0.90
0.21
1.1
1.2
—
—
—
0
0
(3021374) Sirolimus [Mass/volume] in Blood
0
9
0.00
0.21
0.0
6.8
—
6.5
—
0
9
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
9
0.00
0.21
0.0
1.1
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
13
75
1.22
0.21
2.1
1.7
%
7.0
12.3
—
7
45
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
53
406
0.92
0.21
2.2
2.5
%
40.2
36.9
0.39
21
145
(3020491) Glucose [Moles/volume] in Blood
106
705
1.06
0.21
2.1
2.3
mmol/l
7.5
7.3
0.24
79
470
(3023520) Reticulocytes [#/volume] in Blood
1614
11224
1.01
0.21
2.2
2.4
e9/l
65.2
67.4
1.68
1220
8568
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
55
357
1.09
0.21
2.0
1.8
nmol/l
13.5
14.3
0.38
47
323
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
32
251
0.90
0.20
1.4
1.5
%
10.1
9.4
0.03
11
127
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
47
304
1.09
0.19
1.5
1.6
nmol/l
6.0
5.7
0.03
42
257
(3000570) Elastase.pancreatic [Mass/mass] in Stool
409
2956
0.97
0.19
1.4
1.4
ug/g
267.8
259.5
0.37
219
1825
(3051101) Glucose [Moles/volume] in Cord blood
32
250
0.90
0.19
5.4
6.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
11
94
0.82
0.19
1.4
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
22
136
1.14
0.18
1.5
1.7
umol/l
42.2
46.5
0.38
22
136
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
29
183
1.12
0.18
1.2
1.4
%
81.0
74.7
0.57
22
154
(3024263) Appearance of Synovial fluid
84
558
1.06
0.18
1.5
1.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
10
86
0.82
0.18
1.9
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
235
1711
0.97
0.18
1.1
1.1
u/ml
7.3
12.7
—
6
85
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
71
470
1.06
0.17
3.6
2.8
u/l
234.1
217.1
0.93
71
463
(3022493) Free Hemoglobin [Mass/volume] in Plasma
60
452
0.94
0.17
1.1
2.7
mg/l
67.3
65.3
0.10
34
303
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
48
0.73
0.17
1.0
1.0
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
30
191
1.11
0.17
1.0
1.3
mmol/l
0.7
1.6
1.02
16
117
(3051593) INR in Capillary blood by Coagulation assay
116
782
1.05
0.16
9.4
12.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
108
727
1.05
0.16
1.1
1.2
miu/ml
236.6
219.6
0.08
13
198
(3026692) Albumin [Mass/volume] in Peritoneal fluid
33
254
0.92
0.16
1.4
1.4
g/l
13.3
15.4
0.65
23
199
(3051611) Lipemic interference index of Serum or Plasma
172
1254
0.97
0.15
3.4
3.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
5460
38645
0.99
0.15
3.1
3.3
ng/l
2390.4
1984.5
5.93
4578
33844
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
28
179
1.10
0.15
1.0
1.3
u/l
35.5
241.0
0.59
17
121
(3052851) Hemolysis interference index of Serum or Plasma
500
3461
1.02
0.14
3.6
3.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
644
4473
1.01
0.13
2.8
3.1
pmol/l
4.3
4.3
0.29
514
3838
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
23
178
0.91
0.12
1.7
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
20
156
0.90
0.12
1.0
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
31
202
1.08
0.12
1.0
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
13
80
1.15
0.11
1.1
1.1
u/l
24.8
9.1
0.61
13
80
(3023383) Lactate [Moles/volume] in Pleural fluid
71
478
1.05
0.11
1.2
1.3
mmol/l
3.8
3.3
0.65
62
436
(3026389) Candida sp identified in Specimen by Organism specific culture
183
1256
1.03
0.11
1.4
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
40
300
0.94
0.11
1.4
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
39
258
1.07
0.11
1.1
1.1
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
39
258
1.07
0.11
1.3
1.3
%
25.9
31.1
0.42
26
163
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
25
162
1.09
0.11
1.1
1.3
ug/l
68.5
110.4
1.03
16
99
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
909
6470
0.99
0.11
4.7
6.0
mmol/l
25.0
24.8
0.83
890
6395
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
351
2516
0.98
0.11
1.3
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
1381
9652
1.01
0.11
4.8
6.8
—
—
—
0
0
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
5
31
1.14
0.10
1.0
1.1
—
0.1
—
0
14
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
32
1.10
0.10
1.6
1.6
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
14
88
1.12
0.09
2.1
1.9
%
82.1
64.3
—
9
63
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
10
61
1.16
0.09
1.1
1.2
—
—
—
0
0
(44806118)
139
1004
0.98
0.09
1.3
1.3
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
216
1550
0.98
0.08
1.2
1.4
nmol/l
0.9
0.8
0.39
164
1270
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
28
185
1.07
0.08
1.1
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
540
3845
0.99
0.08
2.4
2.9
g/l
0.4
0.3
0.43
179
1535
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
47
1.05
0.08
1.1
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
757
5288
1.01
0.08
3.5
3.9
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
16
103
1.09
0.07
1.5
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
10340
72948
1.00
0.07
6.0
7.6
u/l
82.7
82.2
0.29
9382
68147
(3044927) Protein electrophoresis panel - Urine
204
1413
1.02
0.07
1.3
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1253
8778
1.01
0.07
2.3
2.4
u/l
32.2
38.2
3.26
1018
7430
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
65
0.87
0.07
1.8
1.5
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
8
66
0.85
0.07
1.0
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
105
757
0.98
0.06
1.7
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
34
251
0.95
0.06
1.1
1.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
123
884
0.98
0.06
2.1
1.8
mu/l
363.1
304.1
0.71
113
810
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
67
486
0.97
0.06
1.0
1.1
nmol/l
2.1
10.8
1.84
12
110
(44790049)
140
1004
0.98
0.06
1.3
1.3
—
—
—
0
0
(44790047)
140
1004
0.98
0.06
1.3
1.3
—
—
—
0
0
(44790048)
140
1004
0.98
0.06
1.3
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
119
855
0.98
0.06
1.2
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
101
727
0.98
0.05
1.3
1.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
12
77
1.10
0.05
1.0
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
217
1512
1.01
0.04
1.3
1.4
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
38
259
1.03
0.04
1.1
1.2
mmol/l
1.5
1.5
0.04
23
156
(3028433) Virus identified in Specimen by Culture
44
301
1.03
0.04
1.1
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
12
78
1.08
0.04
1.0
1.1
—
—
—
0
0
(44806420)
62
446
0.98
0.03
2.3
2.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
26
176
1.04
0.03
1.2
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
2582
18224
1.00
0.03
2.2
2.6
umol/l
10.7
11.7
9.22
2215
16634
(3000285) Sodium [Moles/volume] in Blood
24
176
0.96
0.03
1.4
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
78
557
0.99
0.02
3.4
3.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
63
437
1.02
0.02
1.0
1.0
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
150
1049
1.01
0.01
1.3
1.5
u/l
13.0
13.5
0.47
139
1003
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
38
273
0.98
0.01
2.8
2.5
mmol/l
7.1
7.8
0.75
25
181
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
12
80
1.06
0.01
1.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
175
1239
1.00
0.01
1.3
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1517
10682
1.00
0.00
2.1
2.6
umol/l
10.4
9.7
0.45
1229
9268
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
58
413
0.99
0.00
2.2
2.8
—
—
—
0
0
(4212803)
18
123
1.03
0.00
1.1
1.0
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
30
211
1.00
0.00
3.4
2.7
ml/dl
14.9
14.5
0.25
24
194
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
36
254
1.00
0.00
1.3
1.5
ug/l
0.4
0.4
0.06
13
138
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
18
130
0.98
0.00
1.1
1.2
ng/l
214.5
846.4
—
10
83
(3005011) Chlamydia sp Ab [Titer] in Serum
12
82
1.03
0.00
1.8
1.9
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
8
59
0.96
0.00
1.3
1.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
9
65
0.98
0.00
1.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
9
69
0.92
0.00
1.6
1.3
—
—
—
0
0
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
35
1.01
0.00
1.6
1.5
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
31.0
—
0
6
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
9
70
0.91
0.00
1.0
1.0
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028468) Fragments [Presence] in Blood by Light microscopy
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011324) Intrinsic factor Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
1.0
—
0
5
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
50
0.99
0.00
1.0
1.1
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
0
6
0.00
0.00
0.0
1.8
—
5.7
—
0
6
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009220) Epithelial cells.squamous [#/volume] in Urine sediment
0
5
0.00
0.00
0.0
1.2
—
3.4
—
0
5
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
9
68
0.93
0.00
1.2
1.1
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759632) Porphyrins [Mass/mass] in Stool
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: KRA_PSY_DEMENTIA – Any dementia
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).